KR101229045B1 - Extracting method of nelumbo nucifera flower, leaf, stem, root, seed and cosmetic composition for anti-wrinkle containing extracts thereby - Google Patents
Extracting method of nelumbo nucifera flower, leaf, stem, root, seed and cosmetic composition for anti-wrinkle containing extracts thereby Download PDFInfo
- Publication number
- KR101229045B1 KR101229045B1 KR1020100034504A KR20100034504A KR101229045B1 KR 101229045 B1 KR101229045 B1 KR 101229045B1 KR 1020100034504 A KR1020100034504 A KR 1020100034504A KR 20100034504 A KR20100034504 A KR 20100034504A KR 101229045 B1 KR101229045 B1 KR 101229045B1
- Authority
- KR
- South Korea
- Prior art keywords
- lotus
- root
- stem
- lotus root
- leaf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 240000002853 Nelumbo nucifera Species 0.000 title claims abstract description 220
- 235000006508 Nelumbo nucifera Nutrition 0.000 title claims abstract description 220
- 239000000284 extract Substances 0.000 title claims abstract description 82
- 239000000203 mixture Substances 0.000 title claims abstract description 44
- 239000002537 cosmetic Substances 0.000 title claims abstract description 38
- 238000000034 method Methods 0.000 title claims abstract description 19
- 230000001153 anti-wrinkle effect Effects 0.000 title claims abstract description 9
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 141
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 39
- 235000013372 meat Nutrition 0.000 claims abstract description 23
- -1 foundation Substances 0.000 claims description 58
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 35
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 23
- 239000006210 lotion Substances 0.000 claims description 23
- 239000006071 cream Substances 0.000 claims description 18
- 230000000694 effects Effects 0.000 claims description 17
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 14
- 230000037303 wrinkles Effects 0.000 claims description 13
- 238000001914 filtration Methods 0.000 claims description 11
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 10
- 238000009472 formulation Methods 0.000 claims description 10
- 230000006872 improvement Effects 0.000 claims description 9
- 235000016709 nutrition Nutrition 0.000 claims description 9
- 230000035764 nutrition Effects 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 9
- 235000011187 glycerol Nutrition 0.000 claims description 8
- 238000003809 water extraction Methods 0.000 claims description 8
- 239000008213 purified water Substances 0.000 claims description 6
- 230000003020 moisturizing effect Effects 0.000 claims description 5
- 239000000344 soap Substances 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 3
- 239000006260 foam Substances 0.000 claims description 3
- 239000008269 hand cream Substances 0.000 claims description 3
- 235000013336 milk Nutrition 0.000 claims description 3
- 239000008267 milk Substances 0.000 claims description 3
- 210000004080 milk Anatomy 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 2
- 210000003205 muscle Anatomy 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 abstract description 5
- 230000008859 change Effects 0.000 description 57
- 210000003491 skin Anatomy 0.000 description 22
- 238000012360 testing method Methods 0.000 description 20
- 235000014113 dietary fatty acids Nutrition 0.000 description 18
- 239000000194 fatty acid Substances 0.000 description 18
- 229930195729 fatty acid Natural products 0.000 description 18
- 239000002253 acid Substances 0.000 description 16
- 238000000605 extraction Methods 0.000 description 16
- 206010040954 Skin wrinkling Diseases 0.000 description 12
- 239000003921 oil Substances 0.000 description 12
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 10
- 235000019198 oils Nutrition 0.000 description 10
- 150000003839 salts Chemical class 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 9
- 108010035532 Collagen Proteins 0.000 description 9
- 102000008186 Collagen Human genes 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 229920001436 collagen Polymers 0.000 description 9
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- 229920001577 copolymer Polymers 0.000 description 7
- 239000000686 essence Substances 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 239000003925 fat Substances 0.000 description 7
- 235000019197 fats Nutrition 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- 229940088594 vitamin Drugs 0.000 description 7
- 229930003231 vitamin Natural products 0.000 description 7
- 235000013343 vitamin Nutrition 0.000 description 7
- 239000011782 vitamin Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 230000032683 aging Effects 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 6
- 241001474374 Blennius Species 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 239000004909 Moisturizer Substances 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000007796 conventional method Methods 0.000 description 5
- 231100000135 cytotoxicity Toxicity 0.000 description 5
- 230000003013 cytotoxicity Effects 0.000 description 5
- 230000005484 gravity Effects 0.000 description 5
- 230000001333 moisturizer Effects 0.000 description 5
- 229920001296 polysiloxane Polymers 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 235000015112 vegetable and seed oil Nutrition 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- 102000016387 Pancreatic elastase Human genes 0.000 description 4
- 108010067372 Pancreatic elastase Proteins 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 229960005305 adenosine Drugs 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 4
- 230000002849 elastaseinhibitory effect Effects 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- 239000001023 inorganic pigment Substances 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 235000014593 oils and fats Nutrition 0.000 description 4
- 239000012860 organic pigment Substances 0.000 description 4
- 235000021317 phosphate Nutrition 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 229920000223 polyglycerol Polymers 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 239000012488 sample solution Substances 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- 239000004215 Carbon black (E152) Substances 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- 102000016942 Elastin Human genes 0.000 description 3
- 108010014258 Elastin Proteins 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 239000004166 Lanolin Substances 0.000 description 3
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 3
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 239000002280 amphoteric surfactant Substances 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 239000000440 bentonite Substances 0.000 description 3
- 229910000278 bentonite Inorganic materials 0.000 description 3
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 3
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 210000004207 dermis Anatomy 0.000 description 3
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229920002549 elastin Polymers 0.000 description 3
- 231100000321 erythema Toxicity 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 239000011737 fluorine Substances 0.000 description 3
- 229910052731 fluorine Inorganic materials 0.000 description 3
- 239000013538 functional additive Substances 0.000 description 3
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 3
- 229910001385 heavy metal Inorganic materials 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 3
- 229940039717 lanolin Drugs 0.000 description 3
- 235000019388 lanolin Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 238000011076 safety test Methods 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 150000003408 sphingolipids Chemical class 0.000 description 3
- 238000013112 stability test Methods 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 229960000984 tocofersolan Drugs 0.000 description 3
- 229940011671 vitamin b6 Drugs 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- 239000002076 α-tocopherol Substances 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical group C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 2
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 2
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 2
- DHGBAFGZLVRESL-UHFFFAOYSA-N 14-methylpentadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C DHGBAFGZLVRESL-UHFFFAOYSA-N 0.000 description 2
- UWNADWZGEHDQAB-UHFFFAOYSA-N 2,5-dimethylhexane Chemical group CC(C)CCC(C)C UWNADWZGEHDQAB-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- 235000019489 Almond oil Nutrition 0.000 description 2
- ZCTQGTTXIYCGGC-UHFFFAOYSA-N Benzyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 229920001287 Chondroitin sulfate Polymers 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 2
- 241000510678 Falcaria vulgaris Species 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 231100000002 MTT assay Toxicity 0.000 description 2
- 238000000134 MTT assay Methods 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 239000008168 almond oil Substances 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 229960000686 benzalkonium chloride Drugs 0.000 description 2
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical class [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- SHZIWNPUGXLXDT-UHFFFAOYSA-N caproic acid ethyl ester Natural products CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 229940059329 chondroitin sulfate Drugs 0.000 description 2
- 229930016911 cinnamic acid Natural products 0.000 description 2
- 235000013985 cinnamic acid Nutrition 0.000 description 2
- 230000036570 collagen biosynthesis Effects 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- RAPXDXJBAYUBHI-UHFFFAOYSA-N decyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCCCCCC RAPXDXJBAYUBHI-UHFFFAOYSA-N 0.000 description 2
- 239000007933 dermal patch Substances 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000003974 emollient agent Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- MVLVMROFTAUDAG-UHFFFAOYSA-N ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC MVLVMROFTAUDAG-UHFFFAOYSA-N 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000000417 fungicide Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- CRSOQBOWXPBRES-UHFFFAOYSA-N neopentane Chemical compound CC(C)(C)C CRSOQBOWXPBRES-UHFFFAOYSA-N 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 235000019488 nut oil Nutrition 0.000 description 2
- 239000010466 nut oil Substances 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- OQILCOQZDHPEAZ-UHFFFAOYSA-N octyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 2
- AFDXODALSZRGIH-UHFFFAOYSA-N p-coumaric acid methyl ether Natural products COC1=CC=C(C=CC(O)=O)C=C1 AFDXODALSZRGIH-UHFFFAOYSA-N 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- ZQBAKBUEJOMQEX-UHFFFAOYSA-N phenyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 ZQBAKBUEJOMQEX-UHFFFAOYSA-N 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 235000008160 pyridoxine Nutrition 0.000 description 2
- 239000011677 pyridoxine Substances 0.000 description 2
- 238000005057 refrigeration Methods 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 229940117986 sulfobetaine Drugs 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristoyl-sn-glycerol Natural products CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 2
- 235000019871 vegetable fat Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 229920003169 water-soluble polymer Polymers 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- 235000004835 α-tocopherol Nutrition 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- WFXHUBZUIFLWCV-UHFFFAOYSA-N (2,2-dimethyl-3-octanoyloxypropyl) octanoate Chemical compound CCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCC WFXHUBZUIFLWCV-UHFFFAOYSA-N 0.000 description 1
- DEQUKPCANKRTPZ-UHFFFAOYSA-N (2,3-dihydroxyphenyl)-phenylmethanone Chemical compound OC1=CC=CC(C(=O)C=2C=CC=CC=2)=C1O DEQUKPCANKRTPZ-UHFFFAOYSA-N 0.000 description 1
- BOCBOJPUWMTAJB-UHFFFAOYSA-N (2-butylphenyl) 2-hydroxybenzoate Chemical compound CCCCC1=CC=CC=C1OC(=O)C1=CC=CC=C1O BOCBOJPUWMTAJB-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- PFKYCGAUNWCWNO-UHFFFAOYSA-N 1,5-diphenyl-1h-tetrazol-1-ium;bromide Chemical compound [Br-].C1=CC=CC=C1[NH+]1C(C=2C=CC=CC=2)=NN=N1 PFKYCGAUNWCWNO-UHFFFAOYSA-N 0.000 description 1
- KZEVSDGEBAJOTK-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[5-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CC=1OC(=NN=1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O KZEVSDGEBAJOTK-UHFFFAOYSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- OUZOBPPZPCBJAR-UHFFFAOYSA-N 14-methylpentadecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C OUZOBPPZPCBJAR-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- WPIOBXGJZUSKGK-UHFFFAOYSA-N 16-methylheptadecyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC(C)C WPIOBXGJZUSKGK-UHFFFAOYSA-N 0.000 description 1
- MVUWRLHKGKEGSS-UHFFFAOYSA-N 16-methylheptadecyl octanoate Chemical compound CCCCCCCC(=O)OCCCCCCCCCCCCCCCC(C)C MVUWRLHKGKEGSS-UHFFFAOYSA-N 0.000 description 1
- FUTGDWNFCMWSJT-UHFFFAOYSA-N 2,3-bis(14-methylpentadecanoyloxy)propyl 14-methylpentadecanoate Chemical compound CC(C)CCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCC(C)C FUTGDWNFCMWSJT-UHFFFAOYSA-N 0.000 description 1
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- WEKLUCWCJWZVGP-UHFFFAOYSA-N 2-(2-dodecoxy-2-oxoethyl)-2-hydroxybutanedioic acid Chemical compound CCCCCCCCCCCCOC(=O)CC(O)(C(O)=O)CC(O)=O WEKLUCWCJWZVGP-UHFFFAOYSA-N 0.000 description 1
- QZJDYFVPLXBWTK-UHFFFAOYSA-N 2-(diethylamino)ethyl octadecanoate Chemical class CCCCCCCCCCCCCCCCCC(=O)OCCN(CC)CC QZJDYFVPLXBWTK-UHFFFAOYSA-N 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N 2-Ethylhexanoic acid Chemical compound CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- KIHBGTRZFAVZRV-UHFFFAOYSA-N 2-Hydroxyoctadecanoic acid Natural products CCCCCCCCCCCCCCCCC(O)C(O)=O KIHBGTRZFAVZRV-UHFFFAOYSA-N 0.000 description 1
- YJLUBHOZZTYQIP-UHFFFAOYSA-N 2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CC2=C(CC1)NN=N2 YJLUBHOZZTYQIP-UHFFFAOYSA-N 0.000 description 1
- ZMXUPLNMYABPEB-UHFFFAOYSA-N 2-[[2-(dodecanoylamino)acetyl]amino]acetic acid Chemical compound CCCCCCCCCCCC(=O)NCC(=O)NCC(O)=O ZMXUPLNMYABPEB-UHFFFAOYSA-N 0.000 description 1
- QUBNFZFTFXTLKH-UHFFFAOYSA-N 2-aminododecanoic acid Chemical compound CCCCCCCCCCC(N)C(O)=O QUBNFZFTFXTLKH-UHFFFAOYSA-N 0.000 description 1
- AKVBCGQVQXPRLD-UHFFFAOYSA-N 2-aminooctanoic acid Chemical compound CCCCCCC(N)C(O)=O AKVBCGQVQXPRLD-UHFFFAOYSA-N 0.000 description 1
- DIFKERPSKZJYML-UHFFFAOYSA-N 2-ethyl-2-(hydroxymethyl)propane-1,3-diol;octadecanoic acid Chemical compound CCC(CO)(CO)CO.CCCCCCCCCCCCCCCCCC(O)=O DIFKERPSKZJYML-UHFFFAOYSA-N 0.000 description 1
- GLCFQKXOQDQJFZ-UHFFFAOYSA-N 2-ethylhexyl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OCC(CC)CCCC GLCFQKXOQDQJFZ-UHFFFAOYSA-N 0.000 description 1
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 1
- QXJLVVPDMZWUSN-UHFFFAOYSA-N 2-hexyloctadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(C(O)=O)CCCCCC QXJLVVPDMZWUSN-UHFFFAOYSA-N 0.000 description 1
- LVYLCBNXHHHPSB-UHFFFAOYSA-N 2-hydroxyethyl salicylate Chemical compound OCCOC(=O)C1=CC=CC=C1O LVYLCBNXHHHPSB-UHFFFAOYSA-N 0.000 description 1
- LEEDMQGKBNGPDN-UHFFFAOYSA-N 2-methylnonadecane Chemical compound CCCCCCCCCCCCCCCCCC(C)C LEEDMQGKBNGPDN-UHFFFAOYSA-N 0.000 description 1
- HTNFLUQQANUSLR-UHFFFAOYSA-N 2-octanoyloxyethyl octanoate Chemical compound CCCCCCCC(=O)OCCOC(=O)CCCCCCC HTNFLUQQANUSLR-UHFFFAOYSA-N 0.000 description 1
- GECRRQVLQHRVNH-MRCUWXFGSA-N 2-octyldodecyl (z)-octadec-9-enoate Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC GECRRQVLQHRVNH-MRCUWXFGSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QULIOZDJZXKLNY-UHFFFAOYSA-N 3,4,5-trihydroxy-2-propylbenzoic acid Chemical compound CCCC1=C(O)C(O)=C(O)C=C1C(O)=O QULIOZDJZXKLNY-UHFFFAOYSA-N 0.000 description 1
- ZYIFAFPFZXUPAX-UHFFFAOYSA-N 3-(dimethylamino)propyl octadecanoate Chemical class CCCCCCCCCCCCCCCCCC(=O)OCCCN(C)C ZYIFAFPFZXUPAX-UHFFFAOYSA-N 0.000 description 1
- SDZHIRPZKXFSBX-UHFFFAOYSA-N 3-(dodecanoylamino)propanoic acid;zinc Chemical compound [Zn].CCCCCCCCCCCC(=O)NCCC(O)=O SDZHIRPZKXFSBX-UHFFFAOYSA-N 0.000 description 1
- VOUAQYXWVJDEQY-QENPJCQMSA-N 33017-11-7 Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)CCC1 VOUAQYXWVJDEQY-QENPJCQMSA-N 0.000 description 1
- 125000000972 4,5-dimethylthiazol-2-yl group Chemical group [H]C([H])([H])C1=C(N=C(*)S1)C([H])([H])[H] 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- YPIFGDQKSSMYHQ-UHFFFAOYSA-M 7,7-dimethyloctanoate Chemical compound CC(C)(C)CCCCCC([O-])=O YPIFGDQKSSMYHQ-UHFFFAOYSA-M 0.000 description 1
- ODMZDMMTKHXXKA-QXMHVHEDSA-N 8-methylnonyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCCCCCCC(C)C ODMZDMMTKHXXKA-QXMHVHEDSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- QZCLKYGREBVARF-UHFFFAOYSA-N Acetyl tributyl citrate Chemical compound CCCCOC(=O)CC(C(=O)OCCCC)(OC(C)=O)CC(=O)OCCCC QZCLKYGREBVARF-UHFFFAOYSA-N 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- BMFMQGXDDJALKQ-BYPYZUCNSA-N Argininic acid Chemical compound NC(N)=NCCC[C@H](O)C(O)=O BMFMQGXDDJALKQ-BYPYZUCNSA-N 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 108010075254 C-Peptide Proteins 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- FTFSBTUNGWWUHI-UHFFFAOYSA-N CC(C(C(CO)(CO)CO)CC)(C)C Chemical compound CC(C(C(CO)(CO)CO)CC)(C)C FTFSBTUNGWWUHI-UHFFFAOYSA-N 0.000 description 1
- HVODQUYZKSKPKN-UHFFFAOYSA-N CCCC1(CCCCCCC1)CC Chemical compound CCCC1(CCCCCCC1)CC HVODQUYZKSKPKN-UHFFFAOYSA-N 0.000 description 1
- JIAVUMAJCIDZOU-UHFFFAOYSA-N CCCCCCCCCC(CCCCCC)OC(=O)CCCCCC(C)(C)C Chemical compound CCCCCCCCCC(CCCCCC)OC(=O)CCCCCC(C)(C)C JIAVUMAJCIDZOU-UHFFFAOYSA-N 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical compound NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 241000195628 Chlorophyta Species 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241000544061 Cuculus canorus Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-araboascorbic acid Natural products OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- AERBNCYCJBRYDG-UHFFFAOYSA-N D-ribo-phytosphingosine Natural products CCCCCCCCCCCCCCC(O)C(O)C(N)CO AERBNCYCJBRYDG-UHFFFAOYSA-N 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 238000011891 EIA kit Methods 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 229940122858 Elastase inhibitor Drugs 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- PYVHTIWHNXTVPF-UHFFFAOYSA-N F.F.F.F.C=C Chemical compound F.F.F.F.C=C PYVHTIWHNXTVPF-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 235000000072 L-ascorbyl-6-palmitate Nutrition 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 239000004640 Melamine resin Substances 0.000 description 1
- 229920000877 Melamine resin Polymers 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- GWFGDXZQZYMSMJ-UHFFFAOYSA-N Octadecansaeure-heptadecylester Natural products CCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCCCC GWFGDXZQZYMSMJ-UHFFFAOYSA-N 0.000 description 1
- RJECHNNFRHZQKU-UHFFFAOYSA-N Oelsaeurecholesterylester Natural products C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)CCCCCCCC=CCCCCCCCC)C2 RJECHNNFRHZQKU-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- RODZIAKMFCIGPL-UHFFFAOYSA-N P.I.I Chemical compound P.I.I RODZIAKMFCIGPL-UHFFFAOYSA-N 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- NKSOSPOXQKNIKJ-CLFAGFIQSA-N Polyoxyethylene dioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCOC(=O)CCCCCCC\C=C/CCCCCCCC NKSOSPOXQKNIKJ-CLFAGFIQSA-N 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 108010050808 Procollagen Proteins 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 241000206572 Rhodophyta Species 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 244000044822 Simmondsia californica Species 0.000 description 1
- 235000004433 Simmondsia californica Nutrition 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Natural products C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- 229920001807 Urea-formaldehyde Polymers 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- TUYRNAGGIJZRNM-LBHUVFDKSA-N [(2s)-2-[(2r)-4-hexadecanoyloxy-3-hydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethyl] hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(OC(=O)CCCCCCCCCCCCCCC)=C1O TUYRNAGGIJZRNM-LBHUVFDKSA-N 0.000 description 1
- PRLUQOOFPFWUKQ-KKTNLPSRSA-N [(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl] (z)-octadec-9-enoate Chemical compound C1C[C@@H]2[C@@]3(C)CC[C@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)C[C@@H]3CC[C@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@]21C PRLUQOOFPFWUKQ-KKTNLPSRSA-N 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- WUBKCBOQNXUQDU-UHFFFAOYSA-N [2-(dihydroxymethoxy)phenyl]-phenylmethanone Chemical compound OC(O)OC1=CC=CC=C1C(=O)C1=CC=CC=C1 WUBKCBOQNXUQDU-UHFFFAOYSA-N 0.000 description 1
- YRXGUZPUZBCGST-UHFFFAOYSA-N [2-(hydroxymethoxy)phenyl]-phenylmethanone Chemical compound OCOC1=CC=CC=C1C(=O)C1=CC=CC=C1 YRXGUZPUZBCGST-UHFFFAOYSA-N 0.000 description 1
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000004442 acylamino group Chemical group 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- NGHOLYJTSCBCGC-VAWYXSNFSA-N benzyl cinnamate Chemical group C=1C=CC=CC=1/C=C/C(=O)OCC1=CC=CC=C1 NGHOLYJTSCBCGC-VAWYXSNFSA-N 0.000 description 1
- VZWMKHUMEIECPK-UHFFFAOYSA-M benzyl-dimethyl-octadecylazanium;bromide Chemical class [Br-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 VZWMKHUMEIECPK-UHFFFAOYSA-M 0.000 description 1
- 229940073609 bismuth oxychloride Drugs 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- AGNCRIYGRWNVIF-UHFFFAOYSA-N calcium;2-(dodecanoylamino)acetic acid Chemical compound [Ca].CCCCCCCCCCCC(=O)NCC(O)=O AGNCRIYGRWNVIF-UHFFFAOYSA-N 0.000 description 1
- CEGYXKLZALIAEI-UHFFFAOYSA-N calcium;2-(dodecanoylamino)ethanesulfonic acid Chemical compound [Ca].CCCCCCCCCCCC(=O)NCCS(O)(=O)=O CEGYXKLZALIAEI-UHFFFAOYSA-N 0.000 description 1
- YEFORLIOCBRMFS-UHFFFAOYSA-N calcium;2-(hexadecanoylamino)ethanesulfonic acid Chemical compound [Ca].CCCCCCCCCCCCCCCC(=O)NCCS(O)(=O)=O YEFORLIOCBRMFS-UHFFFAOYSA-N 0.000 description 1
- HOQGRRFKKLWWOO-UHFFFAOYSA-N calcium;3-(dodecanoylamino)propanoic acid Chemical compound [Ca].CCCCCCCCCCCC(=O)NCCC(O)=O HOQGRRFKKLWWOO-UHFFFAOYSA-N 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- HIAAVKYLDRCDFQ-UHFFFAOYSA-L calcium;dodecanoate Chemical compound [Ca+2].CCCCCCCCCCCC([O-])=O.CCCCCCCCCCCC([O-])=O HIAAVKYLDRCDFQ-UHFFFAOYSA-L 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
- 150000001840 cholesterol esters Chemical class 0.000 description 1
- XHRPOTDGOASDJS-UHFFFAOYSA-N cholesterol n-octadecanoate Natural products C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)CCCCCCCCCCCCCCCCC)C2 XHRPOTDGOASDJS-UHFFFAOYSA-N 0.000 description 1
- 229940072104 cholesteryl hydroxystearate Drugs 0.000 description 1
- RJECHNNFRHZQKU-RMUVNZEASA-N cholesteryl oleate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)C1 RJECHNNFRHZQKU-RMUVNZEASA-N 0.000 description 1
- XHRPOTDGOASDJS-XNTGVSEISA-N cholesteryl stearate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCCCC)C1 XHRPOTDGOASDJS-XNTGVSEISA-N 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- VQWFNAGFNGABOH-UHFFFAOYSA-K chromium(iii) hydroxide Chemical compound [OH-].[OH-].[OH-].[Cr+3] VQWFNAGFNGABOH-UHFFFAOYSA-K 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 229910052570 clay Inorganic materials 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 210000003022 colostrum Anatomy 0.000 description 1
- 235000021277 colostrum Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- UPWQHKLZCDYJOU-UHFFFAOYSA-N decanoic acid;2,2-dimethylpropane-1,3-diol Chemical compound OCC(C)(C)CO.CCCCCCCCCC(O)=O.CCCCCCCCCC(O)=O UPWQHKLZCDYJOU-UHFFFAOYSA-N 0.000 description 1
- OFADGACXTNUQLM-UHFFFAOYSA-N decanoic acid;propane-1,2-diol Chemical compound CC(O)CO.CCCCCCCCCC(O)=O.CCCCCCCCCC(O)=O OFADGACXTNUQLM-UHFFFAOYSA-N 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 230000005786 degenerative changes Effects 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- WZPMZMCZAGFKOC-UHFFFAOYSA-N diisopropyl hydrogen phosphate Chemical compound CC(C)OP(O)(=O)OC(C)C WZPMZMCZAGFKOC-UHFFFAOYSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical class [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- MIMDHDXOBDPUQW-UHFFFAOYSA-N dioctyl decanedioate Chemical compound CCCCCCCCOC(=O)CCCCCCCCC(=O)OCCCCCCCC MIMDHDXOBDPUQW-UHFFFAOYSA-N 0.000 description 1
- WPUMTJGUQUYPIV-JIZZDEOASA-L disodium (S)-malate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](O)CC([O-])=O WPUMTJGUQUYPIV-JIZZDEOASA-L 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 239000004664 distearyldimethylammonium chloride (DHTDMAC) Chemical class 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- SNPLKNRPJHDVJA-UHFFFAOYSA-N dl-panthenol Chemical compound OCC(C)(C)C(O)C(=O)NCCCO SNPLKNRPJHDVJA-UHFFFAOYSA-N 0.000 description 1
- UCYFZDNMZYZSPN-UHFFFAOYSA-N docosyl(trimethyl)azanium Chemical class CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)C UCYFZDNMZYZSPN-UHFFFAOYSA-N 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 239000003602 elastase inhibitor Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- 235000010350 erythorbic acid Nutrition 0.000 description 1
- 239000004318 erythorbic acid Substances 0.000 description 1
- HPMLGOFBKNGJAM-ONEGZZNKSA-N ethyl (e)-3-(1h-imidazol-5-yl)prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CN=CN1 HPMLGOFBKNGJAM-ONEGZZNKSA-N 0.000 description 1
- FMMOOAYVCKXGMF-MURFETPASA-N ethyl linoleate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC FMMOOAYVCKXGMF-MURFETPASA-N 0.000 description 1
- 229940031016 ethyl linoleate Drugs 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229940124600 folk medicine Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229960002389 glycol salicylate Drugs 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 239000002874 hemostatic agent Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- FPMPNVIMFPEKRN-UHFFFAOYSA-N hexyl 16-methylheptadecanoate Chemical compound CCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C FPMPNVIMFPEKRN-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 150000002462 imidazolines Chemical class 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 229940026239 isoascorbic acid Drugs 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N lauric acid triglyceride Natural products CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 239000012035 limiting reagent Substances 0.000 description 1
- 229940049918 linoleate Drugs 0.000 description 1
- FMMOOAYVCKXGMF-UHFFFAOYSA-N linoleic acid ethyl ester Natural products CCCCCC=CCC=CCCCCCCCC(=O)OCC FMMOOAYVCKXGMF-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- LAQFLZHBVPULPL-UHFFFAOYSA-N methyl(phenyl)silicon Chemical compound C[Si]C1=CC=CC=C1 LAQFLZHBVPULPL-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 229960002900 methylcellulose Drugs 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 238000012009 microbiological test Methods 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- NKBWPOSQERPBFI-UHFFFAOYSA-N octadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCCCC NKBWPOSQERPBFI-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- OSGWZUKVSBHPGZ-UHFFFAOYSA-N octanoic acid;propane-1,2-diol Chemical compound CC(O)CO.CCCCCCCC(O)=O.CCCCCCCC(O)=O OSGWZUKVSBHPGZ-UHFFFAOYSA-N 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- YPMOZWCBANATQH-UHFFFAOYSA-N octyl 7-methyloctanoate Chemical compound CCCCCCCCOC(=O)CCCCCC(C)C YPMOZWCBANATQH-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- IIGMITQLXAGZTL-UHFFFAOYSA-N octyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCC IIGMITQLXAGZTL-UHFFFAOYSA-N 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 125000001232 pantothenyl group Chemical group C(CCNC([C@H](O)C(C)(C)CO)=O)(=O)* 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000010702 perfluoropolyether Substances 0.000 description 1
- 239000005011 phenolic resin Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 229960000969 phenyl salicylate Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- LYKRPDCJKSXAHS-UHFFFAOYSA-N phenyl-(2,3,4,5-tetrahydroxyphenyl)methanone Chemical compound OC1=C(O)C(O)=CC(C(=O)C=2C=CC=CC=2)=C1O LYKRPDCJKSXAHS-UHFFFAOYSA-N 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- AERBNCYCJBRYDG-KSZLIROESA-N phytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO AERBNCYCJBRYDG-KSZLIROESA-N 0.000 description 1
- 229940033329 phytosphingosine Drugs 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920001083 polybutene Polymers 0.000 description 1
- 229920005668 polycarbonate resin Polymers 0.000 description 1
- 239000004431 polycarbonate resin Substances 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- XEIOPEQGDSYOIH-MURFETPASA-N propan-2-yl (9z,12z)-octadeca-9,12-dienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC(C)C XEIOPEQGDSYOIH-MURFETPASA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 239000010499 rapseed oil Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960001755 resorcinol Drugs 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 230000036555 skin type Effects 0.000 description 1
- 235000019265 sodium DL-malate Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 239000001394 sodium malate Substances 0.000 description 1
- 229940074404 sodium succinate Drugs 0.000 description 1
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 1
- 229910052979 sodium sulfide Inorganic materials 0.000 description 1
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical class [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- YFGAFXCSLUUJRG-WCCKRBBISA-M sodium;(2s)-2-amino-5-(diaminomethylideneamino)pentanoate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCCN=C(N)N YFGAFXCSLUUJRG-WCCKRBBISA-M 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- ZUFONQSOSYEWCN-UHFFFAOYSA-M sodium;2-(methylamino)acetate Chemical compound [Na+].CNCC([O-])=O ZUFONQSOSYEWCN-UHFFFAOYSA-M 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- WEAPVABOECTMGR-UHFFFAOYSA-N triethyl 2-acetyloxypropane-1,2,3-tricarboxylate Chemical compound CCOC(=O)CC(C(=O)OCC)(OC(C)=O)CC(=O)OCC WEAPVABOECTMGR-UHFFFAOYSA-N 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- APVVRLGIFCYZHJ-UHFFFAOYSA-N trioctyl 2-hydroxypropane-1,2,3-tricarboxylate Chemical compound CCCCCCCCOC(=O)CC(O)(C(=O)OCCCCCCCC)CC(=O)OCCCCCCCC APVVRLGIFCYZHJ-UHFFFAOYSA-N 0.000 description 1
- COXJMKGEQAWXNP-UHFFFAOYSA-N tris(14-methylpentadecyl) 2-hydroxypropane-1,2,3-tricarboxylate Chemical compound CC(C)CCCCCCCCCCCCCOC(=O)CC(O)(C(=O)OCCCCCCCCCCCCCC(C)C)CC(=O)OCCCCCCCCCCCCCC(C)C COXJMKGEQAWXNP-UHFFFAOYSA-N 0.000 description 1
- RHNXTZDKMRCKKT-UHFFFAOYSA-N tris(6-methylheptyl) 2-hydroxypropane-1,2,3-tricarboxylate Chemical compound CC(C)CCCCCOC(=O)CC(O)(C(=O)OCCCCCC(C)C)CC(=O)OCCCCCC(C)C RHNXTZDKMRCKKT-UHFFFAOYSA-N 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 235000013799 ultramarine blue Nutrition 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 연꽃, 연잎, 연줄기, 연근, 연자육의 열수 추출 방법 및 그에 의하여 제조된 추출물을 유효 성분으로 하는 주름 개선 효과를 가지는 화장료 조성물에 관한 것으로서, 더욱 상세하게는 연꽃, 연잎, 연줄기, 연근, 연자육을 분리하여, 상기 분리된 연꽃, 연잎, 연줄기, 연근, 연자육을 각각 열수 추출하는 것을 특징으로 하는 열수 추출 방법과 상기 열수 추출 방법에 의하여 제조된 연꽃, 연잎, 연줄기, 연근, 연자육의 열수 추출물을 유효 성분으로 하는 주름 개선 효과를 가지는 화장료 조성물을 제공한다.The present invention relates to a method of extracting the hot water of lotus, lotus leaf, lotus stem, lotus root, and lotus root, and a cosmetic composition having an anti-wrinkle effect as an active ingredient, more specifically lotus, lotus leaf, lotus stem, Lotus water, lotus leaf, lotus leaf, lotus root, lotus stem, lotus root, lotus root, lotus root, lotus root, lotus root, lotus root, lotus root, lotus root, lotus root, lotus root, Provided is a cosmetic composition having an anti-wrinkle effect having the hot water extract of lotus root meat as an active ingredient.
Description
본 발명은 연꽃, 연잎, 연줄기, 연근, 연자육의 열수 추출 방법 및 그에 의하여 제조된 추출물을 유효 성분으로 하는 주름 개선 효과를 가지는 화장료 조성물에 관한 것이다.
The present invention relates to a method of extracting the hot water of lotus, lotus leaf, lotus stem, lotus root, lotus root, and a cosmetic composition having an anti-wrinkle effect having the extract prepared thereby as an active ingredient.
우리나라는 급속히 고령화가 진행되는 대표적인 국가로 알려져 있다. 따라서 추후 고령자용 물품의 수요가 계속적으로 증가할 것이 확실시된다. 미국, 일본 등에서는 고령자들을 목표로 한 다양한 화장품들이 개발되어 시판되고 있는 반면, 국내에서는 화장품 분야에서는 딱히 고령자용 화장품이라고 하는 품목들이 출시되고 있지 않다.
Korea is known as a representative country that is rapidly aging. Therefore, it is clear that the demand for articles for the elderly will continue to increase. In the United States and Japan, various cosmetics aimed at the elderly are being developed and marketed, while in the domestic cosmetics, there are no items called cosmetics for the elderly.
피부 노화는 태양광선에 노출되지 않는 부위에서 나타나는 연대학적 노화 (chronologic aging)와 태양광선의 노출부에서 일어나는 퇴행성 변화가 연대학적 노화와 복합되어 일어나는 광인성 노화 (actinic ageing)로 구분된다. 연대학적 노화에서는 특징적인 임상 피부소견으로 미세한 주름, 진피의 위축, 피하지방층의 감소 등이 관찰된다. 광노화 과정에서는 거칠고 깊은 주름 (coatse wrinkling and furrowing)이 나타나고 비정상적인 탄력질양 물질 (elastotic material)이 축적되어 피부가 가죽같이 두터워지며 느슨해진다.Skin aging is divided into chronologic aging in areas not exposed to sunlight and actinic aging, in which degenerative changes in the sun's exposed areas are combined with chronological aging. In chronological aging, characteristic clinical signs of skin are fine wrinkles, atrophy of dermis, and decrease of subcutaneous fat layer. In the photoaging process, coatse wrinkling and furrowing appear and abnormal elasticity material accumulates and the skin thickens and loosens like leather.
피부를 구성하는 세포에서는 피부 노화에 의해 세포활성이 떨어지고, 신호전달체계가 불완전해지면서 피부조직을 분해하는 효소인 MMPs (matrix metalloproteinases)의 생합성이 증가하고, 콜라겐의 생합성이 감소하여 주름살이 생기고 탄력이 감소하는 것으로 알려져 있다. 콜라겐은 피부에 강도와 장력을 부여하며 이로 인해 외부의 자극이나 힘으로부터 피부를 보호하는 역할을 하며 진피층의 90%를 차지하고 있어 콜라겐의 감소는 피부와 노화와 밀접한 관계를 가지고 있다. 따라서 피부 세포를 증식시키거나, 피부를 구성하는 기질물질을 증가시킴으로써 피부를 두껍게 할 수 있는 물질, 피부를 구성하는 기질 물질인 콜라겐을 분해하는 MMPs의 생합성을 억제할 수 있는 물질, 멜라닌 생합성을 억제할 수 있는 물질 등이 주름, 탄력 상실, 피부 흑화 등의 피부 증상을 완화시키는 것으로 밝혀져 있다.
In the cells constituting the skin, the cell activity decreases due to skin aging, the signaling system is incomplete, and the biosynthesis of MMPs (matrix metalloproteinases), an enzyme that breaks down the skin tissue, increases. This is known to decrease. Collagen gives skin strength and tension, which protects the skin from external irritation or force, and makes up 90% of the dermal layer. Collagen reduction is closely related to skin and aging. Therefore, by proliferating the skin cells or increasing the substrate constituting the skin, melanin biosynthesis, a substance that can thicken the skin and a substance that can inhibit the biosynthesis of MMPs that degrade collagen, a substrate constituting the skin Substances that can be used have been found to relieve skin symptoms such as wrinkles, loss of elasticity, and skin blackening.
이러한 물질 중의 하나로 연(蓮, Nelumbo nucifera)이 주목받고 있다. 연은 뿌리, 줄기, 잎, 열매 등 다양한 부위가 식품 또는 한약재로서 오랫동안 사용되어서 그 안전성이 상당히 입증된 식물이며 가격 또한 kg 당 2,000원 정도로 비교적 저렴하여 화장품 소재로는 이상적인 환경을 갖추고 있다. 연은 전국 재배면적이 약 550ha로서 많은 양이 생산되고 있으며 주요산지로는 경남 함안, 칠서, 한림, 하빈과 대구 반야월, 전남 곡성군 등이 알려져 있다. One of these substances, lotus (Nelumbo nucifera) is attracting attention. Kite is a plant that has been used for a long time as a food or herbal medicine for various parts such as roots, stem, leaves and fruit, and its safety is quite proven. Yeongeon has about 550 hectares of cultivated area in Korea. The major production areas are Haman, Chilseo, Hanlim, Harbin, Daegu Banyeol, Jeonnam, and Gyeongseong.
연의 항노화효과는 다양한 중의학문헌에 소개되고 있으며, 본초강목에서는 연은 기력을 왕성하게 하고 모든 질병을 물리치며 오래 복용하면 몸이 가벼워지고 수명을 연장한다고 기록되어 있다. 약성본초에는 연은 오장육부의 기운부족, 특히 심, 비, 신의 기운부족과 속이 상한 것을 낫게 하며 12경맥의 기혈을 크게 보하고, 쌀과 연육으로 죽을 쑤어 먹으면 몸이 가볍고 든든하여지며 또 머리칼을 검게하고 장수하게한다고 쓰여 있다. 연꽃은 주로 관상용으로 애용되고 있으나 용도는 크게 연구되지 않았으며, 특히 잎은 알칼로이드와 탄닌을 함유하고 있어 수렴 및 지혈제로 사용되거나 민간에서는 야뇨증을 치료하는데에 이용되고 있기도 하다. 땅속 줄기는 연근이라 하며 아스파라진이 들어 있어 식용하며 자양 강장약으로 쓰인다. 열매는 연방, 씨를 연자육이라고 하며 부인병에 좋다고 알려져 있다.
Yan's anti-aging effects have been introduced in various Chinese medicine literatures, and the herbaceous tree is said to have a strong energy, fight all diseases, and take longer to lighten the body and prolong its life. In medicinal herb, kite relieves the lack of energy of the five Jangyuk, especially the lack of energy of the heart, rain, and god, and greatly improves the blood flow of 12 veins, and makes rice light and strong by eating porridge with rice and beef. It is written to make it black and long life. Lotus flower is mainly used for ornamental purposes, but its use has not been studied much. Especially, the leaf contains alkaloid and tannin, which is used as astringent and hemostatic agent or in the folk medicine to treat enuresis. Underground stems are called lotus root and are used as edible tonic because they contain asparagine. The fruit is federal, the seed is called Yeonjagi and is known to be good for gynecological diseases.
종래 연꽃을 이용하여 화장료 조성물을 제조하는 기술에 대한 연구가 진행되고 있었으나, 종래 기술에서는 연을 꽃, 줄기, 뿌리 등의 부위로 분리하지 않고 통째로 추출하여 추출 효과가 떨어지고, 연 이외의 다른 물질을 첨가하는 방법으로 효과를 보충하여 제조 공정이 복잡하다는 문제점이 있었다.
Conventional researches have been conducted on a technique for preparing a cosmetic composition using a lotus flower, but in the prior art, a kite extracts the whole without separating it into parts such as flowers, stems, roots, etc., and the extraction effect is lowered. There was a problem that the manufacturing process is complicated by supplementing the effect by the addition method.
본 발명은 상기와 같은 문제점을 해결하기 위하여 연을 연꽃, 연잎, 연줄기, 연근, 연자육으로 구분하고, 각각의 부위에 대해 개별적으로 열수 추출을 행하여 얻어지는 열수 추출물을 유효 성분으로 하는 주름 개선 효과를 가지는 화장료 조성물을 제공하는 것을 그 목적으로 한다.
The present invention divides the lotus into lotus, lotus leaf, lotus stem, lotus root, lotus root meat in order to solve the above problems, and to improve the wrinkles effect of using the hydrothermal extract obtained by performing hydrothermal extraction for each site individually Eggplant aims to provide a cosmetic composition.
본 발명은 상기와 같은 목적을 해결하기 위하여 The present invention to solve the above object
i)연꽃, 연잎, 연줄기, 연근, 연자육을 분리하는 단계;i) separating the lotus, lotus leaf, lotus stem, lotus root, lotus meat;
ii)상기 i)단계에서 분리된 연꽃, 연잎, 연줄기, 연근, 연자육을 각각 별도로 열수 추출하여 각각 냉각하는 단계;ii) extracting the lotus flower, the long leaf, the stems, the rootstocks, and the pods separately from the step i) separately and cooling them;
iii)상기 ii)단계에서 얻어진 냉각된 연꽃, 연잎, 연줄기, 연근, 연자육의 열수 추출물을 각각 1차 여과하는 단계;iii) primary filtration of each of the chilled lotus, the lotus leaf, the stalks, the lotus root, and the hot water extract obtained in step ii);
iv)상기 iii)단계에서 얻어진 연꽃, 연잎, 연줄기, 연근, 연자육의 열수 추출물을 각각 4℃ 내지 6℃에서 24시간 침지시키는 단계;iv) immersing the hot water extract of the lotus flower, the long leaf, the stems, the lotus root, and the soft meat obtained in the step iii) at 4 ° C to 6 ° C for 24 hours;
v)상기 iv)단계에서 얻어진 연꽃, 연잎, 연줄기, 연근, 연자육의 열수 추출물을 각각 2차 여과하는 단계;로 구성되는 연꽃, 연잎, 연줄기, 연근, 연자육의 열수 추출 방법을 제공한다.
v) filtering the hot water extracts of lotus, lotus leaf, lotus stem, lotus root, and lotus root respectively obtained in step iv); provides a method of extracting the hot water of lotus, lotus leaf, lotus stem, lotus root, lotus root.
본 발명에 있어서, 상기 ii)단계에서의 열수 추출은 연꽃, 연잎, 연줄기, 연근, 연자육 100 g 당 용매 3000 ml 내지 4000 ml를 가하고 100℃ 내지 120℃에서 최초 부피의 50%의 부피가 될 때까지 가열하는 것을 특징으로 한다.
In the present invention, the hot water extraction in step ii) is added to 3000 ml to 4000 ml of solvent per 100 g of lotus flower, lotus leaf, lotus stem, lotus root, lotus root meat and the volume of 50% of the initial volume at 100 ℃ to 120 ℃ It is characterized by heating until.
본 발명에 있어서, 상기 ii)단계의 열수 추출 단계를 2회 내지 5회 반복하는 것을 특징으로 한다.
In the present invention, it is characterized in that the hot water extraction step of step ii) is repeated 2 to 5 times.
본 발명에 있어서, 상기 용매는 정제수를 포함하는 물, 에탄올을 포함하는 C1 내지 C4의 저급알콜, 글리세린, 부틸렌글리콜, 프로필렌글리콜, 함수 에탄올, 함수 프로필렌글리콜, 함수 부틸렌글리콜로 구성된 그룹으로부터 선택된 하나 이상인 것을 특징으로 한다.
In the present invention, the solvent is a group consisting of water containing purified water, C 1 to C 4 lower alcohol, glycerine, butylene glycol, propylene glycol, hydrous ethanol, hydrous propylene glycol, hydrous butylene glycol It is characterized in that at least one selected from.
또한, 본 발명은 상기 본 발명의 열수 추출 방법에 의하여 제조된 연꽃, 연잎, 연줄기, 연근, 연자육의 열수 추출물을 유효 성분으로 하는 주름 개선 효과를 가지는 화장료 조성물을 제공한다.
In addition, the present invention provides a cosmetic composition having a wrinkle improvement effect of using the hot water extract of lotus flower, lotus leaf, lotus stem, lotus root, lotus root meat prepared by the hot water extraction method of the present invention as an active ingredient.
본 발명에 있어서, 상기 주름 개선 효과를 가지는 화장료 조성물은 상기 연꽃, 연잎, 연줄기, 연근, 연자육의 열수 추출물을 전체 화장료 조성물 대비 각각 0.01 중량% 내지 5 중량% 함유하는 것을 특징으로 한다.
In the present invention, the cosmetic composition having an anti-wrinkle effect is characterized in that it contains 0.01 wt% to 5 wt% of the hot water extracts of the lotus, lotus leaf, lotus stem, lotus root, and lotus root respectively compared to the total cosmetic composition.
본 발명에 있어서, 상기 화장료 조성물은 스킨로션, 스킨소프너, 스킨토너, 아스트린젠트, 로션, 밀크로션, 모이스쳐 로션, 영양로션, 맛사지크림, 영양크림, 모이스처크림, 핸드크림, 파운데이션, 에센스, 영양에센스, 팩, 비누, 클렌징폼, 클렌징로션, 클렌징크림, 바디로션 및 바디클린저의 제형으로 구성된 그룹에서 선택된 하나 이상의 제형을 가지는 것을 특징으로 한다.
In the present invention, the cosmetic composition is a skin lotion, skin softener, skin toner, astringent, lotion, milk lotion, moisturizing lotion, nutrition lotion, massage cream, nutrition cream, moisture cream, hand cream, foundation, essence, nutrition essence, It is characterized by having one or more formulations selected from the group consisting of packs, soaps, cleansing foams, cleansing lotions, cleansing creams, body lotions and body cleansers.
본 발명의 연꽃, 연잎, 연줄기, 연근, 연자육의 열수 추출 방법에 의하여 제조된 추출물을 유효 성분으로 하는 주름 개선 효과를 가지는 화장료 조성물에 의하면, 연의 각 부위를 대상으로 개별적으로 추출한 추출물을 사용하여 뛰어난 주름 개선 효과를 통한 피부 노화 방지를 제공할 수 있다.
According to the cosmetic composition having a wrinkle improvement effect using the extract prepared by the method of extracting the hot water of lotus, lotus leaf, lotus stem, lotus root, and lotus root of the present invention as an active ingredient, the extract is individually extracted for each part of the lotus using Excellent anti-wrinkle effect can provide skin anti-aging.
도 1은 본 발명의 실시예에 따른 연 추출물의 안전성 시험(MTT assay) 결과를 나타내는 그래프이다.
도 2는 본 발명의 실시예에 따른 연 추출물의 엘라스타제 억제 효과 시험 결과를 나타내는 그래프이다.
도 3은 본 발명의 실시예에 따른 연 추출물의 콜라겐 합성 효과 시험 결과를 나타내는 그래프이다.1 is a graph showing the results of the safety test (MTT assay) of the lotus extract according to an embodiment of the present invention.
Figure 2 is a graph showing the results of the elastase inhibitory effect test of the lotus extract according to the embodiment of the present invention.
Figure 3 is a graph showing the collagen synthesis effect test results of the lotus extract according to the embodiment of the present invention.
이하에서는, 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자가 본 발명을 용이하게 실시할 수 있도록 하기 위하여, 본 발명의 바람직한 실시예들에 관하여 첨부된 도면을 참조하여 상세히 설명하기로 한다.
Hereinafter, preferred embodiments of the present invention will be described in detail with reference to the accompanying drawings, so that those skilled in the art can easily carry out the present invention.
본 발명에 의한 연꽃, 연잎, 연줄기, 연근, 연자육의 열수 추출 방법은Hot water extraction method of the lotus, lotus leaf, lotus stem, lotus root, lotus meat according to the present invention
i)연꽃, 연잎, 연줄기, 연근, 연자육을 분리하는 단계, i) separating the lotus, lotus leaf, lotus stem, lotus root, lotus meat,
ii)상기 i)단계에서 분리된 연꽃, 연잎, 연줄기, 연근, 연자육을 각각 별도로 열수 추출하여 각각 냉각하는 단계, ii) a step of cooling each of the lotus flower, lotus leaf, lotus stem, lotus root, lotus root meat separated in step i) by separately extracting the hot water;
iii)상기 ii)단계에서 얻어진 냉각된 연꽃, 연잎, 연줄기, 연근, 연자육의 열수 추출물을 각각 1차 여과하는 단계, iii) primary filtration of the hydrothermal extracts of the cooled lotus, lotus leaf, lotus stem, lotus root, lotus root meat obtained in step ii), respectively,
iv)상기 iii)단계에서 얻어진 연꽃, 연잎, 연줄기, 연근, 연자육의 열수 추출물을 각각 4℃ 내지 6℃에서 24시간 침지시키는 단계 및 iv) immersing the hot water extract of lotus, lotus leaf, lotus stem, lotus root and lotus root meat obtained in step iii) at 4 ° C. to 6 ° C. for 24 hours, and
v)상기 iv)단계에서 얻어진 연꽃, 연잎, 연줄기, 연근, 연자육의 열수 추출물 각각 2차 여과하는 단계로 구성된다.
v) secondary filtration of each of the hot water extract of lotus, lotus leaf, lotus stem, lotus root, lotus root meat obtained in step iv).
본 발명에 의한 연꽃, 연잎, 연줄기, 연근, 연자육의 열수 추출 방법은 먼저, 연을 연꽃, 연잎, 연줄기, 연근, 연자육의 부위별로 분리시킨다.
In the method of extracting the hot water of the lotus, lotus leaf, lotus stem, lotus root, and lotus root meat according to the present invention, first, the lotus is separated by parts of the lotus, lotus leaf, lotus stem, lotus root and lotus root.
그 다음, 분리시킨 연꽃, 연잎, 연줄기, 연근, 연자육 100 g 당 용매 3000 ml 내지 4000 ml 를 가하고 100℃ 내지 120℃에서 최초 부피의 50% 의 부피가 될 때까지 가열한다(열수 추출). 이 때, 열수 추출 단계를 2회 내지 5회 반복하는 것이 바람직하나, 반드시 이에 한정되는 것은 아니다. 추출 단계를 수회 반복할수록 추출 효과가 높아지나, 5회 이상 실시할 경우 잔여 추출 성분이 미미하여 반복 추출의 의미가 낮아진다. Then, 3000 ml to 4000 ml of solvent per 100 g of the lotus flower, lotus leaf, lotus stem, lotus root and lotus root meat separated are added and heated to 100% of the initial volume at 100 ° C to 120 ° C (hot water extraction). At this time, it is preferable to repeat the hot water extraction step 2 to 5 times, but is not necessarily limited thereto. As the extraction step is repeated several times, the extraction effect is increased. However, when the extraction step is performed five times or more, the residual extraction component is insignificant, and thus the meaning of the repeated extraction becomes low.
추출시 사용되는 상기 용매는 정제수를 포함하는 물, 에탄올을 포함하는 C1 내지 C4의 저급알콜, 글리세린, 부틸렌글리콜, 프로필렌글리콜, 함수 에탄올, 함수 프로필렌글리콜, 함수 부틸렌글리콜로 구성된 그룹으로부터 선택된 하나 이상일 수 있다. 구체적으로, 연잎, 연꽃, 연근, 연자육 또는 연줄기를 건조하여 그 중량의 약 1 내지 50배, 바람직하게는 약 5 내지 30배 부피의 정제수를 포함한 물, 탄소수 1 내지 4의 저급알코올 또는 프로필렌글리콜, 초산에칠, 부틸렌글리콜, 에테르, 글리세린, 클로로포름으로 구성된 그룹으로부터 선택된 하나 이상의 용매일 수 있으나, 반드시 이에 한정되는 것은 아니다.
The solvent used in the extraction is selected from the group consisting of water containing purified water, C 1 to C 4 lower alcohols including ethanol, glycerin, butylene glycol, propylene glycol, hydrous ethanol, hydrous propylene glycol, hydrous butylene glycol It may be one or more selected. Specifically, lotus leaf, lotus, lotus root, lotus root or lotus stem is dried to water containing about 1 to 50 times, preferably about 5 to 30 times the volume of purified water, lower alcohol or propylene glycol having 1 to 4 carbon atoms, One or more solvents selected from the group consisting of ethyl acetate, butylene glycol, ether, glycerin, chloroform, but is not necessarily limited thereto.
그 후, 상기 추출물을 상온까지 냉각하고 방부 처리한 후, 상기 열수 추출물을 여과지를 이용하여 1차 여과를 하고, 1차 여과를 마치면 24시간 동안 냉장에서 4℃ 내지 6℃로 침지시킨다. Thereafter, the extract is cooled to room temperature and subjected to antiseptic treatment, and then the hot water extract is subjected to primary filtration using filter paper, and after completion of the primary filtration, it is immersed at 4 ° C. to 6 ° C. in refrigeration for 24 hours.
상기 여과지는 0.1 내지 1.5㎛ 필터인 것을 이용하여 수행하는 것이 바람직하다. 필터의 기공 사이즈가 0.1㎛ 미만인 경우에는 필터가 초정밀하여 초고가이므로(한외여과법) 경제성이 떨어지는 문제가 있고, 1.5㎛를 초과하는 경우는 제균력이 없어 진균이나 세균의 원물에 포함되어 유통 중 오염될 가능성이 높다는 문제가 있다.The filter paper is preferably performed using a 0.1 to 1.5㎛ filter. If the pore size of the filter is less than 0.1 μm, the filter is very precise and extremely expensive (ultrafiltration method), so there is a problem of inferior economic efficiency. There is a problem that is likely.
24시간 침지시킨 후 상온에서 최종적으로 여과지로 2차 여과하여 보관한다. 이렇게 제조된 추출물은 감압증류 및 동결건조 또는 분무 건조 등과 같은 추가적인 과정에 의하여 분말상태로 제조될 수 있다.
After immersion for 24 hours, the solution is finally filtered through filter paper at room temperature. The extract thus prepared may be prepared in powder form by an additional process such as distillation under reduced pressure and lyophilization or spray drying.
본 발명의 화장료 조성물은 상기와 같이 추출된 연 추출물 각각을 전체 화장료 조성물 대비 바람직하게는 0.01 내지 5중량%, 보다 바람직하게는 0.1 내지 3중량% 로 배합된다. The cosmetic composition of the present invention is preferably blended with each of the extract extracted as described above to 0.01 to 5% by weight, more preferably 0.1 to 3% by weight relative to the total cosmetic composition.
연잎, 연꽃, 연근, 연자육 또는 연줄기로부터 선택되는 연 추출물이 총 중량에 비해 0.01중량% 이하로 포함되면 주름 개선 효과가 미미하고, 5중량% 이상이면 하기 실험예 5에서 확인할 수 있는 바와 같이, 세포 독성에 의하여 안전성이 급격히 떨어지기 때문이다.
When the lotus leaf extract, lotus, lotus root, lotus root or lotus stem selected from the amount of less than 0.01% by weight relative to the total weight of the wrinkle improvement effect is insignificant, 5% by weight or more as can be confirmed in the following Experimental Example 5, This is because safety is drastically deteriorated by cytotoxicity.
본 발명의 화장료에는 상기 제조된 연 추출물 이외에 기능성 첨가물 및 일반적인 화장료 조성물에 포함되는 성분이 추가로 포함될 수 있다. The cosmetic of the present invention may further include functional additives and components included in the general cosmetic composition in addition to the lotus extract prepared above.
상기 기능성 첨가물로는 수용성 비타민, 유용성 비타민, 고분자 펩티드, 고분자 다당, 스핑고 지질 및 해초 엑기스로 이루어진 군에서 선택된 성분을 포함할 수 있다.The functional additives may include water-soluble vitamins, oil-soluble vitamins, polymer peptides, polymeric polysaccharides, sphingolipids and seaweed extracts.
상기 수용성 비타민으로서는 화장품에 배합 가능한 것이라면 어떠한 것이라도 되지만, 바람직하게는 비타민 B1, 비타민 B2, 비타민 B6, 피리독신, 염산피리독신, 비타민 B12, 판토텐산, 니코틴산, 니코틴산아미드, 엽산, 비타민 C, 비타민 H 등을 들 수 있으며, 그들의 염 (티아민염산염, 아스코르빈산나트륨염 등)이나 유도체 (아스코르빈산-2-인산나트륨염, 아스코르빈산-2-인산마그네슘염 등)도 본 발명에서 사용할 수 있는 수용성 비타민에 포함된다. 수용성 비타민은 미생물 변환법, 미생물의 배양물로부터의 정제법, 효소법 또는 화학 합성법 등의 통상의 방법에 의해 수득할 수 있다.The water-soluble vitamins may be any compound as long as they can be incorporated into cosmetics, but preferably vitamin B1, vitamin B2, vitamin B6, pyridoxine, pyridoxine, vitamin B12, pantothenic acid, nicotinic acid, nicotinic acid amide, folic acid, vitamin C, vitamin H, and the like. And salts thereof (thiamine hydrochloride, sodium ascorbate salt, etc.) and derivatives (ascorbic acid-2-sodium phosphate salt, ascorbic acid-2-magnesium phosphate salt, etc.) can also be used in the present invention. Included in The water-soluble vitamins can be obtained by conventional methods such as microbial transformation, purification from microorganism culture, enzyme or chemical synthesis.
상기 유용성 비타민으로서는 화장품에 배합 가능한 것이라면 어떠한 것이라도 되지만, 바람직하게는 비타민 A, 카로틴, 비타민 D2, 비타민 D3, 비타민 E (d1-알파 토코페롤, d-알파 토코페롤, d-알파 토코페롤) 등을 들 수 있으며, 그들의 유도체 (팔미틴산아스코르빈, 스테아르산아스코르빈, 디팔미틴산아스코르빈, 아세트산dl-알파 토코페롤, 니코틴산dl-알파 토코페롤비타민 E, DL-판토테닐알코올, D-판토테닐알코올, 판토테닐에틸에테르 등) 등도 본 발명에서 사용되는 유용성 비타민에 포함된다. 유용성 비타민은 미생물 변환법, 미생물의 배양물로부터의 정제법, 효소 또는 화학 합성법 등의 통상의 방법에 의해 취득할 수 있다.The oil-soluble vitamin may be any compound that can be formulated in cosmetics, but preferably vitamin A, carotene, vitamin D2, vitamin D3, vitamin E (d1-alpha tocopherol, d-alpha tocopherol, d-alpha tocopherol) and the like. And derivatives thereof (ascorbic palmitate, ascorbic stearate, ascorbic acid dipalmitate, dl-alpha tocopherol acetate, dl-alpha tocopherolvitamin E, DL-pantothenyl alcohol, D-pantothenyl alcohol, pantothenyl) Ethyl ether) and the like are also included in the oil-soluble vitamins used in the present invention. Oil-soluble vitamins can be obtained by conventional methods such as microbial transformation, purification of microorganism culture, enzyme or chemical synthesis.
상기 고분자 펩티드로서는 화장품에 배합 가능한 것이라면 어떠한 것이라도 되지만, 바람직하게는 콜라겐, 가수 분해 콜라겐, 젤라틴, 엘라스틴, 가수 분해 엘라스틴, 케라틴 등을 들 수 있다. 고분자 펩티드는 미생물의 배양액으로부터의 정제법, 효소법 또는 화학 합성법 등의 통상의 방법에 의해 정제 취득할 수 있으며, 또는 통상 돼지나 소 등의 진피, 누에의 견섬유 등의 천연물로부터 정제하여 사용할 수 있다.The polymer peptide may be any compound as long as it can be incorporated into cosmetics. Preferably, collagen, hydrolyzed collagen, gelatin, elastin, hydrolyzed elastin, keratin and the like can be given. Polymeric peptides can be purified and obtained by conventional methods such as purification from microbial cultures, enzymatic methods or chemical synthesis methods, or can be purified and used from natural products such as dermis and pig silk such as pigs and cattle.
상기 고분자 다당으로서는 화장품에 배합 가능한 것이라면 어떠한 것이라도 되지만, 바람직하게는 히드록시에틸셀룰로오스, 크산탄검, 히알루론산나트륨, 콘드로이틴 황산 또는 그 염 (나트륨염 등) 등을 들 수 있다. 예를 들어, 콘드로이틴 황산 또는 그 염 등은 통상 포유 동물이나 어류로부터 정제하여 사용할 수 있다. The polymer polysaccharide may be any compound as long as it can be blended into cosmetics. Preferably, hydroxyethyl cellulose, xanthan gum, sodium hyaluronate, chondroitin sulfate or a salt thereof (sodium salt, etc.) may be mentioned. For example, chondroitin sulfate or a salt thereof can be usually purified from mammals or fish.
상기 스핑고 지질로서는 화장품에 배합 가능한 것이라면 어떠한 것이라도 되지만, 바람직하게는 세라미드, 피토스핑고신, 스핑고당지질 등을 들 수 있다. 스핑고 지질은 통상 포유류, 어류, 패류, 효모 또는 식물 등으로부터 통상의 방법에 의해 정제하거나 화학 합성법에 의해 취득할 수 있다. The sphingolipid may be any compound as long as it can be incorporated into cosmetics. Preferably, ceramide, phytosphingosine, sphingosaccharide lipid, etc. may be mentioned. Sphingo lipids can usually be purified from mammals, fish, shellfish, yeasts or plants by conventional methods or obtained by chemical synthesis.
상기 엑기스로는 화장품에 배합 가능한 것이라면 어떠한 것이라도 되지만, 바람직하게는 갈조 엑기스, 홍조 엑기스, 녹조 엑기스 등을 들 수 있으며, 또, 이들의 해초 엑기스로부터 정제된 칼라기난, 아르긴산, 아르긴산나트륨, 아르긴산칼륨 등도 본 발명에서 사용되는 해초 엑기스에 포함된다. 해초 엑기스는 해초로부터 통상의 방법에 의해 정제하여 취득할 수 있다.
The extract may be any compound as long as it can be formulated in cosmetics, and preferably, brown algae extract, red algae extract, green algae extract, and the like can be used. Further, calginine, arginic acid, sodium arginate purified from these seaweed extracts, Potassium arginate and the like are also included in the seaweed extract used in the present invention. Seaweed extract can be obtained by purification from seaweed by conventional methods.
본 발명의 화장료 조성물에는 또한, 상기 기능성 첨가물과 더불어 필요에 따라 일반적인 화장료 조성물에 포함되는 성분을 배합해도 된다. 이외에 포함되는 배합 성분으로서는 유지 성분, 보습제, 에몰리엔트제, 계면 활성제, 유기 및 무기 안료, 유기 분체, 자외선 흡수제, 방부제, 살균제, 산화 방지제, 식물 추출물, pH 조정제, 알콜, 색소, 향료, 혈행 촉진제, 냉감제, 제한(制汗)제, 정제수 등을 들 수 있다.In addition to the said functional additive, you may mix | blend the component contained in a general cosmetic composition with the cosmetic composition of this invention as needed. In addition to the other components included, oils and fats, moisturizers, emollients, surfactants, organic and inorganic pigments, organic powders, ultraviolet absorbers, preservatives, fungicides, antioxidants, plant extracts, pH adjusters, alcohols, pigments, flavorings, blood circulation And accelerators, cooling agents, limiting agents, purified water, and the like.
상기 유지 성분으로서는 에스테르계 유지, 탄화수소계 유지, 실리콘계 유지, 불소계 유지, 동물 유지, 식물 유지 등을 들 수 있다.Examples of the fat or oil component include ester fats, hydrocarbon fats, silicone fats, fluorine fats, animal fats, and vegetable fats and oils.
상기 에스테르계 유지로서는 트리2-에틸헥산산글리세릴, 2-에틸헥산산세틸, 미리스틴산이소프로필, 미리스틴산부틸, 팔미틴산이소프로필, 스테아르산에틸, 팔미틴산옥틸, 이소스테아르산이소세틸, 스테아르산부틸, 리놀레산에틸, 리놀레산이소프로필, 올레인산에틸, 미리스틴산이소세틸, 미리스틴산이소스테아릴, 팔미틴산이소스테아릴, 미리스틴산옥틸도데실, 이소스테아르산이소세틸, 세바신산디에틸, 아디핀산디이소프로필, 네오펜탄산이소알킬, 트리(카프릴, 카프린산)글리세릴, 트리2-에틸헥산산트리메틸롤프로판, 트리이소스테아르산트리메틸롤프로판, 테트라2-에틸헥산산펜타엘리슬리톨, 카프릴산세틸, 라우린산데실, 라우린산헥실, 미리스틴산데실, 미리스틴산미리스틸, 미리스틴산세틸, 스테아르산스테아릴, 올레인산데실, 리시노올레인산세틸, 라우린산이소스테아릴, 미리스틴산이소트리데실, 팔미틴산이소세틸, 스테아르산옥틸, 스테아르산이소세틸, 올레인산이소데실, 올레인산옥틸도데실, 리놀레산옥틸도데실, 이소스테아르산이소프로필, 2-에틸헥산산세토스테아릴, 2-에틸헥산산스테아릴, 이소스테아르산헥실, 디옥탄산에틸렌글리콜, 디올레인산에틸렌글리콜, 디카프린산프로필렌글리콜, 디(카프릴,카프린산)프로필렌글리콜, 디카프릴산프로필렌글리콜, 디카프린산네오펜틸글리콜, 디옥탄산네오펜틸글리콜, 트리카프릴산글리세릴, 트리운데실산글리세릴, 트리이소팔미틴산글리세릴, 트리이소스테아르산글리세릴, 네오펜탄산옥틸도데실, 옥탄산이소스테아릴, 이소노난산옥틸, 네오데칸산헥실데실, 네오데칸산옥틸도데실, 이소스테아르산이소세틸, 이소스테아르산이소스테아릴, 이소스테아르산옥틸데실, 폴리글리세린올레인산에스테르, 폴리글리세린이소스테아르산에스테르, 시트르산트리이소세틸, 시트르산트리이소알킬, 시트르산트리이소옥틸, 락트산라우릴, 락트산미리스틸, 락트산세틸, 락트산옥틸데실, 시트르산트리에틸, 시트르산아세틸트리에틸, 시트르산아세틸트리부틸, 시트르산트리옥틸, 말산디이소스테아릴, 히드록시스테아르산 2-에틸헥실, 숙신산디2-에틸헥실, 아디핀산디이소부틸, 세바신산디이소프로필, 세바신산디옥틸,스테아르산콜레스테릴, 이소스테아르산콜레스테릴, 히드록시스테아르산콜레스테릴, 올레인산콜레스테릴, 올레인산디히드로콜레스테릴, 이소스테아르산피트스테릴, 올레인산피트스테릴, 12-스테알로일히드록시스테아르산이소세틸, 12-스테알로일히드록시스테아르산스테아릴, 12-스테알로일히드록시스테아르산이소스테아릴 등의 에스테르계 등을 들 수 있다.Examples of the ester-based oils and fats include glyceryl tri2-ethylhexanoate, cetyl 2-ethylhexanoate, isopropyl myristin, butyl mystinate, isopropyl palmitate, ethyl stearate, octyl palmitate, isocetyl isostearate, and stearic acid. Butyl acid, ethyl linoleate, isopropyl linoleate, ethyl oleate, isocetyl acid isocetyl, isostyl acid isostearyl, isostaryl palmitate, octylate acid octylate dodecyl, isostearic acid isetyl, diethyl sebacinate, adidi Diisopropyl phosphate, isoalkyl neopentane, tri (capryl, capric acid) glyceryl, trimethyl ethyl trimethylolpropane, trimethyl stearate trimethylol propane, tetra 2-ethylhexanopentane Tol, Cetyl Caprylic Acid, decyl laurate, hexyl laurate, mysterylate decyl, myristic acid myristyl, myristicate cetyl, stearyl stearate, decyl oleate, ricinoolein Sancetyl, isostearyl laurate, isotridecyl myristin, isocetyl palmitate, octyl stearate, isocetyl stearate, isodecyl oleate, octyl dodecyl oleate, octyl dodecyl linoleate, isopropyl isopropyl acid , 2-ethylhexanoate cetostearyl, 2-ethylhexanoate stearyl, hexyl isostearate, ethylene glycol dioctanoate, ethylene glycol dioleate, propylene glycol dicapric acid, propylene glycol di (capryl, capric acid) , Propylene glycol dicaprylic acid, neopentyl glycol dicapric acid, neopentyl glycol dioctanoate, glyceryl tricaprylate, glyceryl tritridecyl, glyceryl triisopalmitate, glyceryl triisostearate, octyl neopentane Dodecyl, isostearyl octanoate, octyl isononanoate, hexyldecyl neodecanoate, octyldodecyl neodecanoate, isocetyl isostearate, isostearic isostearic acid Reel, octyldecyl isostearate, polyglycerol oleic acid ester, polyglycerol isostearic acid ester, triisocetyl citrate, triisoalkyl citrate, triisooctyl citrate, lauryl citrate, myritic lactate, cetyl lactate, octyl decate, Triethyl citrate, acetyl triethyl citrate, acetyl tributyl citrate, trioctyl citrate, diisostearyl malic acid, 2-ethylhexyl hydroxystearate, diethyl 2-ethylhexyl succinate, diisobutyl adipicate, diisocebaic acid Propyl, dioctyl sebacate, cholesteryl stearate, cholesteryl isostearic acid, cholesteryl hydroxystearate, cholesteryl oleate, dihydrocholesteryl oleate, physteryl isostearic acid, phytic oleate Reel, 12-Steloylhydroxystearate isocetyl, 12-Steloylhydroxystearate stearyl, 12-ste Esters such as alloylhydroxystearic acid isostearyl; and the like.
상기 탄화 수소계 유지로서는 스쿠알렌, 유동 파라핀, 알파-올레핀올리고머, 이소파라핀, 세레신, 파라핀, 유동 이소파라핀, 폴리부덴, 마이크로크리스탈린왁스, 와셀린 등의 탄화 수소계 유지 등을 들 수 있다.Examples of the hydrocarbon-based oils and fats include hydrocarbon-based oils such as squalene, liquid paraffin, alpha-olefin oligomer, isoparaffin, ceresin, paraffin, liquid isoparaffin, polybutene, microcrystalline wax, and vaseline.
상기 실리콘계 유지로서는 폴리메틸실리콘, 메틸페닐실리콘, 메틸시클로폴리실록산, 옥타메틸폴리실록산, 데카메틸폴리실록산, 도데카메틸시클로실록산, 디메틸실록산ㆍ메틸세틸옥시실록산 공중합체, 디메틸실록산ㆍ메틸스테알록시실록산 공중합체, 알킬 변성 실리콘유, 아미노 변성 실리콘유 등을 들 수 있다.Examples of the silicone-based oils and fats include polymethylsilicone, methylphenylsilicone, methylcyclopolysiloxane, octamethylpolysiloxane, decamethylpolysiloxane, dodecamethylcyclosiloxane, dimethylsiloxane and methylcetyloxysiloxane copolymer, dimethylsiloxane and methylsteoxysiloxane copolymer, Alkyl modified silicone oil, amino modified silicone oil, etc. are mentioned.
상기 불소계 유지로서는 퍼플루오로폴리에테르 등을 들 수 있다.Perfluoro polyether etc. are mentioned as said fluorine-based fat or oil.
상기 동물 또는 식물 유지로서는 아보카도유, 아르몬드유, 올리브유, 참깨유, 쌀겨유, 새플라워유, 대두유, 옥수수유, 유채유, 행인(杏仁)유, 팜핵유, 팜유, 피마자유, 해바라기유, 포도종자유, 면실유, 야자유, 쿠쿠이너트유, 소맥배아유, 쌀 배아유, 시아버터, 월견초유, 마커데이미아너트유, 메도홈유, 난황유, 우지(牛脂), 마유, 밍크유, 오렌지라피유, 호호바유, 캔데리러왁스, 카르나바왁스, 액상 라놀린, 경화피마자유 등의 동물 또는 식물 유지를 들 수 있다.Examples of the animal or vegetable oils include avocado oil, almond oil, olive oil, sesame oil, rice bran oil, soybean oil, soybean oil, corn oil, rapeseed oil, almond oil, palm kernel oil, palm oil, castor oil, sunflower oil, grapes. Seed oil, Cottonseed oil, Palm oil, Cuckoo nut oil, Wheat germ oil, Rice germ oil, Shea butter, Walnut colostrum, Marker demia nut oil, Meadow home oil, Egg yolk oil, Uji, Horse oil, Mink oil, Orange rape oil, Jojoba Animal or vegetable fats and oils, such as oil, candler wax, carnava wax, liquid lanolin, hardened castor oil, etc. are mentioned.
상기 보습제로서는 수용성 저분자 보습제, 지용성 분자 보습제, 수용성 고분자, 지용성 고분자 등을 들 수 있다.As said moisturizer, a water-soluble low molecular moisturizer, a fat-soluble molecular moisturizer, a water-soluble polymer, a fat-soluble polymer, etc. are mentioned.
상기 수용성 저분자 보습제로서는 세린, 글루타민, 솔비톨, 만니톨, 피롤리돈-카르복실산나트륨, 글리세린, 프로필렌글리콜, 1,3-부틸렌글리콜, 에틸렌글리콜, 폴리에틸렌글리콜B(중합도 n = 2 이상), 폴리프로필렌글리콜(중합도 n = 2 이상), 폴리글리세린B(중합도 n = 2 이상), 락트산, 락트산염 등을 들 수 있다.Examples of the water-soluble low molecular moisturizer include serine, glutamine, sorbitol, mannitol, pyrrolidone sodium carboxylate, glycerin, propylene glycol, 1,3-butylene glycol, ethylene glycol, polyethylene glycol B (polymerization degree n = 2 or more), poly Propylene glycol (polymerization degree n = 2 or more), polyglycerol B (polymerization degree n = 2 or more), lactic acid, lactic acid salt, etc. are mentioned.
상기 지용성 저분자 보습제로서는 콜레스테롤, 콜레스테롤에스테르 등을 들 수 있다.Examples of the fat-soluble low molecular humectants include cholesterol and cholesterol esters.
상기 수용성 고분자로서는 카르복시비닐폴리머, 폴리아스파라긴산염, 트라가칸트, 크산탄검, 메틸셀룰로오스, 히드록시메틸셀룰로오스, 히드록시에틸셀룰로오스, 히드록시프로필셀룰로오스, 카르복시메틸셀룰로오스, 수용성 키틴, 키토산, 덱스트린 등을 들 수 있다.Examples of the water-soluble polymers include carboxyvinyl polymer, polyasparaginate, tragacanth, xanthan gum, methyl cellulose, hydroxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, carboxymethyl cellulose, water soluble chitin, chitosan, and dextrin. Can be mentioned.
상기 지용성 고분자로서는 폴리비닐피롤리돈ㆍ에이코센 공중합체, 폴리비닐피롤리돈ㆍ헥사데센 공중합체, 니트로셀룰로오스, 덱스트린지방산에스테르, 고분자 실리콘 등을 들 수 있다.Examples of the fat-soluble polymers include polyvinylpyrrolidone-eicosene copolymers, polyvinylpyrrolidone-hexadecene copolymers, nitrocellulose, dextrin fatty acid esters, polymer silicones, and the like.
상기 에몰리엔트제로서는 장쇄아실글루타민산콜레스테릴에스테르, 히드록시스테아르산콜레스테릴, 12-히드록시스테아르산, 스테아르산, 로진산, 라놀린지방산콜레스테릴에스테르 등을 들 수 있다.As said emollient agent, long-chain acyl glutamic acid cholesteryl ester, hydroxy stearic acid cholesterol, 12-hydroxystearic acid, stearic acid, rosin acid, lanolin fatty acid cholesteryl ester, etc. are mentioned.
상기 계면 활성제로서는 비이온성 계면 활성제, 음이온성 계면 활성제, 양이온성 계면 활성제, 양성 계면 활성제 등을 들 수 있다.As said surfactant, a nonionic surfactant, anionic surfactant, cationic surfactant, an amphoteric surfactant, etc. are mentioned.
상기 비이온성 계면 활성제로서는 자기 유화형 모노스테아르산글리세린, 프로필렌글리콜지방산에스테르, 글리세린지방산에스테르, 폴리글리세린지방산에스테르, 솔비탄지방산에스테르, POE (폴리옥시에틸렌)솔비탄지방산에스테르, POE 솔비트지방산에스테르, POE 글리세린지방산에스테르, POE 알킬에테르, POE 지방산에스테르, POE 경화피마자유, POE 피마자유, POEㆍPOP (폴리옥시에틸렌ㆍ폴리옥시프로필렌) 공중합체, POEㆍPOP 알킬에테르, 폴리에테르변성실리콘, 라우린산알카놀아미드, 알킬아민옥시드, 수소첨가대두인지질 등을 들 수 있다.Examples of the nonionic surfactant include self-emulsifying monoglycerate, propylene glycol fatty acid ester, glycerin fatty acid ester, polyglycerol fatty acid ester, sorbitan fatty acid ester, POE (polyoxyethylene) sorbitan fatty acid ester, POE sorbitan fatty acid ester, POE glycerin fatty acid ester, POE alkyl ether, POE fatty acid ester, POE hardened castor oil, POE castor oil, POE-POP (polyoxyethylene polyoxypropylene) copolymer, POE-POP alkyl ether, polyether modified silicone, laurin Acid alkanolamide, alkylamine oxide, hydrogenated soybean phospholipid, etc. are mentioned.
상기 음이온성 계면 활성제로서는 지방산비누, 알파-아실술폰산염, 알킬술폰산염, 알킬알릴술폰산염, 알킬나프탈렌술폰산염, 알킬황산염, POE 알킬에테르황산염, 알킬아미드황산염, 알킬인산염, POE 알킬인산염, 알킬아미드인산염, 알킬로일알킬타우린염, N-아실아미노산염, POE 알킬에테르카르복실산염, 알킬술포숙신산염, 알킬술포아세트산나트륨, 아실화 가수분해 콜라겐펩티드염, 퍼플루오로알킬인산에스테르 등을 들 수 있다.As the anionic surfactant, fatty acid soap, alpha-acyl sulfonate, alkyl sulfonate, alkyl allyl sulfonate, alkyl naphthalene sulfonate, alkyl sulfate, POE alkyl ether sulfate, alkylamide sulfate, alkyl phosphate, POE alkyl phosphate, alkylamide Phosphates, alkyloylalkyltaurine salts, N-acylamino acid salts, POE alkyl ether carboxylate salts, alkyl sulfosuccinate salts, sodium alkyl sulfo acetates, acylated hydrolyzed collagen peptide salts, perfluoroalkyl phosphate esters, and the like. have.
상기 양이온성 계면 활성제로서는 염화알킬트리메틸암모늄, 염화스테아릴트리메틸암모늄, 브롬화스테아릴트리메틸암모늄, 염화세토스테아릴트리메틸암모늄, 염화디스테아릴디메틸암모늄, 염화스테아릴디메틸벤질암모늄, 브롬화베헤닐트리메틸암모늄, 염화벤잘코늄, 스테아르산디에틸아미노에틸아미드, 스테아르산디메틸아미노프로필아미드, 라놀린 유도체 제 4급 암모늄염 등을 들 수 있다.Examples of the cationic surfactant include alkyltrimethylammonium chloride, stearyltrimethylammonium chloride, stearyl trimethylammonium chloride, cetostearyltrimethylammonium chloride, distearyldimethylammonium chloride, stearyldimethylbenzyl ammonium bromide, behenyltrimethylammonium, Benzalkonium chloride, diethylaminoethyl stearate, dimethylaminopropyl stearate, lanolin derivatives, quaternary ammonium salts, and the like.
상기 양성 계면 활성제로서는 카르복시베타인형, 아미드베타인형, 술포베타인형, 히드록시술포베타인형, 아미드술포베타인형, 포스포베타인형, 아미노카르복실산염형, 이미다졸린 유도체형, 아미드아민형 등의 양성 계면 활성제 등을 들 수 있다.Examples of the amphoteric surfactant include a carboxybetaine type, an amidebetaine type, a sulfobetaine type, a hydroxysulfobetaine type, an amide sulfobetaine type, a phosphobetaine type, an aminocarboxylate type, an imidazoline derivative type, an amideamine type, and the like. Amphoteric surfactants; and the like.
상기 유기 및 무기 안료로서는 규산, 무수규산, 규산마그네슘, 탤크, 세리사이트, 마이카, 카올린, 벵갈라, 클레이, 벤토나이트, 티탄피막운모, 옥시염화비스무트, 산화지르코늄, 산화마그네슘, 산화아연, 산화티탄, 산화알루미늄, 황산칼슘, 황산바륨, 황산마그네슘, 탄산칼슘, 탄산마그네슘, 산화철, 군청, 산화크롬, 수산화크롬, 칼라민 및 이들의 복합체등의 무기 안료 ; 폴리아미드, 폴리에스테르, 폴리프로필렌, 폴리스티렌, 폴리우레탄, 비닐수지, 요소수지, 페놀수지, 불소수지, 규소수지, 아크릴수지, 멜라민수지, 에폭시수지, 폴리카보네이트수지, 디비닐벤젠ㆍ스티렌 공중합체, 실크파우더, 셀룰로오스, CI 피그먼트옐로우, CI 피그먼트오렌지 등의 유기 안료 및 이들의 무기 안료와 유기 안료의 복합 안료 등을 들 수 있다.Examples of the organic and inorganic pigments include silicic acid, silicic anhydride, magnesium silicate, talc, sericite, mica, kaolin, bengal, clay, bentonite, titanium film mica, bismuth oxychloride, zirconium oxide, magnesium oxide, zinc oxide, titanium oxide, and oxide Inorganic pigments such as aluminum, calcium sulfate, barium sulfate, magnesium sulfate, calcium carbonate, magnesium carbonate, iron oxide, ultramarine blue, chromium oxide, chromium hydroxide, coloramine and composites thereof; Polyamide, polyester, polypropylene, polystyrene, polyurethane, vinyl resin, urea resin, phenol resin, fluorine resin, silicon resin, acrylic resin, melamine resin, epoxy resin, polycarbonate resin, divinylbenzene, styrene copolymer, Organic pigments such as silk powder, cellulose, CI pigment yellow, CI pigment orange, and composite pigments of these inorganic pigments and organic pigments;
상기 유기 분체로서는 스테아르산칼슘 등의 금속비누 ; 세틸린산아연나트륨, 라우릴린산아연, 라우릴린산칼슘 등의 알킬인산금속염 ; N-라우로일-베타-알라닌칼슘, N-라우로일-베타-알라닌아연, N-라우로일글리신칼슘 등의 아실아미노산 다가금속염 ; N-라우로일-타우린칼슘, N-팔미토일-타우린칼슘 등의 아미드술폰산 다가금속염 ; N-엡실론-라우로일-L-리진, N-엡실론-팔미토일리진, N-알파-파리토일올니틴, N-알파-라우로일아르기닌, N-알파-경화우지지방산아실아르기닌 등의 N-아실염기성아미노산 ; N-라우로일글리실글리신 등의 N-아실폴리펩티드 ; 알파-아미노카프릴산, 알파-아미노라우린산 등의 알파-아미노지방산 ; 폴리에틸렌, 폴리프로필렌, 나일론, 폴리메틸메타크릴레이트, 폴리스티렌, 디비닐벤젠ㆍ스티렌 공중합체, 사불화에틸렌 등을 들 수 있다.As said organic powder, Metal soaps, such as a calcium stearate; Alkyl phosphate metal salts such as sodium cetylinate, zinc lauryl acid and calcium laurate; Acylamino acid polyvalent metal salts such as N-lauroyl-beta-alanine calcium, N-lauroyl-beta-alanine zinc, and N-lauroylglycine calcium; Amide sulfonic acid polyvalent metal salts, such as N-lauroyl-taurine calcium and N-palmitoyl-taurine calcium; N-epsilon-lauroyl-L-lysine, N-epsilon-palmitolyzine, N-alpha-paratoylol nitin, N-alpha-lauroyl arginine, N-alpha-cured fatty acid acyl arginine -Acyl basic amino acid; N-acyl polypeptides, such as N-lauroyl glycyl glycine; Alpha-amino fatty acids such as alpha-aminocaprylic acid and alpha-aminolauric acid; Polyethylene, polypropylene, nylon, polymethyl methacrylate, polystyrene, divinylbenzene-styrene copolymer, ethylene tetrafluoride and the like.
상기 자외선 흡수제로서는 파라아미노벤조산, 파라아미노벤조산에틸, 파라아미노벤조산아밀, 파라아미노벤조산옥틸, 살리실산에틸렌글리콜, 살리신산페닐, 살리신산옥틸, 살리신산벤질, 살리신산부틸페닐, 살리신산호모멘틸, 계피산벤질, 파라메톡시계피산-2-에톡시에틸, 파라메톡시계피산옥틸, 디파라메톡시계피산모노-2-에틸헥산글리세릴, 파라메톡시계피산이소프로필, 디이소프로필ㆍ디이소프로필계피산에스테르 혼합물, 우로카닌산, 우로카닌산에틸, 히드록시메톡시벤조페논, 히드록시메톡시벤조페논술폰산 및 그 염, 디히드록시메톡시벤조페논, 디히드록시메톡시벤조페논디술폰산나트륨, 디히드록시벤조페논, 테트라히드록시벤조페논, 4-tert-부틸-4'-메톡시디벤조일메탄, 2,4,6-트리아닐리노-p-(카르보-2'-에틸헥실-1'-옥시)-1,3,5-트리아진, 2-(2-히드록시-5-메틸페닐)벤조트리아졸 등을 들 수 있다.As said ultraviolet absorber, paraamino benzoic acid, ethyl paraamino benzoate, amyl paraamino benzoate, octyl paraamino benzoate, ethylene glycol salicylate, phenyl salicylate, octyl salicylate, benzyl salicylate, butylphenyl salicylate, homomentyl salicylic acid, and cinnamic acid Benzyl, paramethoxy cinnamic acid-2-ethoxyethyl, paramethoxy cinnamic acid octyl, diparamethoxy cinnamic acid mono-2-ethylhexaneglyceryl, paramethoxy cinnamic acid isopropyl, diisopropyl diisopropyl cinnamic acid ester mixture, Urocanoic acid, ethyl urocanate, hydroxymethoxybenzophenone, hydroxymethoxybenzophenonesulfonic acid and salts thereof, dihydroxymethoxybenzophenone, dihydroxymethoxybenzophenonedisulfonic acid sodium salt, dihydroxybenzo Phenone, tetrahydroxybenzophenone, 4-tert-butyl-4'-methoxydibenzoylmethane, 2,4,6-trianilino-p- (carbo-2'-ethylhexyl-1'-oxy)- 1,3,5-triazine, 2- (2- And the like can be de-hydroxy-5-methylphenyl) benzotriazole.
상기 살균제로서는 히노키티올, 트리클로산, 트리클로로히드록시디페닐에테르, 크로르헥시딘글루콘산염, 페녹시에탄올, 레조르신, 이소프로필메틸페놀, 아줄렌, 살리칠산, 진크필리티온, 염화벤잘코늄, 감광소 301 호, 모노니트로과이어콜나트륨, 운데시렌산 등을 들 수 있다.Examples of the fungicides include hinokithiol, trichloric acid, trichlorohydroxydiphenyl ether, chlorhexidine gluconate, phenoxyethanol, resorcinol, isopropylmethylphenol, azulene, salicylic acid, zinphylthione, benzalkonium chloride, Photosensitizer No. 301, mononitrourecosodium sodium, undecylenic acid, etc. are mentioned.
상기 산화 방지제로서는 부틸히드록시아니솔, 갈릭산프로필, 엘리소르빈산 등을 들 수 있다.Examples of the antioxidant include butylhydroxyanisole, propyl gallic acid, and erythorbic acid.
상기 pH 조정제로서는 시트르산, 시트르산나트륨, 말산, 말산나트륨, 프말산, 프말산나트륨, 숙신산, 숙신산나트륨, 수산화나트륨, 인산일수소나트륨 등을 들 수 있다.Examples of the pH adjuster include citric acid, sodium citrate, malic acid, sodium malate, fmaric acid, sodium fmarate, succinic acid, sodium succinate, sodium hydroxide, sodium monohydrogen phosphate, and the like.
상기 알코올로서는 세틸알코올 등의 고급 알코올을 들 수 있다.
Higher alcohols, such as cetyl alcohol, are mentioned as said alcohol.
본 발명의 주름 개선용 기능성 화장료 조성물은 당업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어 유액, 크림, 화장수, 팩, 파운데이션, 로션, 미용액, 모발 화장료 등을 들 수 있다.Functional cosmetic composition for improving wrinkles of the present invention can be prepared in any formulation commonly prepared in the art, for example, emulsion, cream, lotion, pack, foundation, lotion, essence, hair cosmetics and the like. .
구체적으로, 본 발명의 화장료 조성물은 스킨로션, 스킨소프너, 스킨토너, 아스트린젠트, 로션, 밀크로션, 모이스쳐 로션, 영양로션, 맛사지크림, 영양크림, 모이스처크림, 핸드크림, 파운데이션, 에센스, 영양에센스, 팩, 비누, 클렌징폼, 클렌징로션, 클렌징크림, 바디로션 및 바디클린저의 제형을 포함할 수 있다.Specifically, the cosmetic composition of the present invention skin lotion, skin softener, skin toner, astringent, lotion, milk lotion, moisturizing lotion, nutrition lotion, massage cream, nutrition cream, moisturizing cream, hand cream, foundation, essence, nutrition essence, Formulations of packs, soaps, cleansing foams, cleansing lotions, cleansing creams, body lotions and body cleansers.
본 발명의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물섬유, 식물섬유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation of the present invention is a paste, cream or gel, animal fiber, plant fiber, wax, paraffin, starch, tracant, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide may be used as the carrier component .
본 발명의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.When the formulation of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used, and especially in the case of spray, additionally chlorofluorohydrocarbon, propane Propellant such as butane or dimethyl ether.
본 발명의 제형이 용액 또는 유탁액의 경우에는 담체 성분으로서 용매, 용매화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌 글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 있다.In the case of the solution or emulsion of the present invention, a solvent, a solvent or an emulsifier is used as a carrier component, and examples thereof include water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, , 3-butyl glycol oil, glycerol aliphatic ester, polyethylene glycol or sorbitan fatty acid esters.
본 발명의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다.When the formulation of the present invention is a suspension, a carrier such as water, a liquid diluent such as ethanol or propylene glycol, a suspending agent such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, Cellulose, aluminum metahydroxide, bentonite, agar or tracant, etc. may be used.
본 발명의 제형이 계면-활성제 함유 클린징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르 설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 리놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다.
When the formulation of the present invention is a surfactant-containing cleansing, the carrier component is an aliphatic alcohol sulfate, an aliphatic alcohol ether sulfate, a sulfosuccinic acid monoester, an isethionate, an imidazolinium derivative, a methyltaurate, a sarcosinate, a fatty acid amide. Ether sulfates, alkylamidobetaines, aliphatic alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable oils, linolin derivatives or ethoxylated glycerol fatty acid esters and the like can be used.
이하, 본 발명을 하기 실시예 및 실험예에 의해 상세히 설명한다.Hereinafter, the present invention will be described in detail with reference to the following examples and experimental examples.
단, 하기 실시예 및 실험예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예 및 실험예에 의해 한정되는 것은 아니다.
However, the following examples and experimental examples are illustrative of the present invention, and the content of the present invention is not limited by the following examples and experimental examples.
< 실시예 1> 연근 추출물의 제조 <Example 1> Preparation of lotus root extract
연근 50g을 정제수 2000ml에 첨가하여 약 100℃에서 50%중량이 되도록 열수 추출하였다(1회 추출). 그 다음, 물 2000ml를 다시 넣고 100℃에서 50% 중량이 되도록 열수 추출하였다(2회 추출). 물 2000ml를 다시 넣고 100℃에서 50% 중량이 되도록 열수 추출하였다(3회 추출). 그 후, 상온까지 냉각 후 방부 처리하였다. (부틸렌글라이콜 20%, 페노닙(Phenonip) 0.5%). 그리고나서 200mesh(0.75㎛) 여과지를 이용하여 1차 여과를 하고, 1차 여과를 마치면 24시간 동안 냉장에서 침지하였다. 1일 경과 후 상온에서 혼합막여과지(Mixde Cellulose Ester Filter)(0.45㎛)로 최종 여과하여 보관하였다. 50 g of lotus root was added to 2000 ml of purified water, followed by hot water extraction to obtain 50% weight at about 100 ° C (single extraction). Then, 2000 ml of water was put back and hydrothermal extraction was performed at 100 ° C. to 50% weight (extracted twice). 2000 ml of water was added again, and hydrothermal extraction was performed at 100 ° C. to 50% weight (3 times extraction). Thereafter, the mixture was cooled to room temperature and then subjected to antiseptic treatment. (20% butylene glycol, 0.5% phenonip). Then, the first filtration using a 200mesh (0.75㎛) filter paper, and after the first filtration was immersed in refrigeration for 24 hours. After 1 day, the final filtration was stored in a mixed membrane filter (Mixde Cellulose Ester Filter) (0.45㎛) at room temperature.
그 결과 노란색이고, pH 5.30, 비중(Specific gravity) 1.020인 연근 추출물을 얻었다.
As a result, a lotus root extract of yellow color, pH 5.30, and specific gravity of 1.020 was obtained.
< 실시예 2> 연잎 추출물의 제조 <Example 2> Preparation of lotus leaf extract
연잎에 대하여 상기 실시예 1과 동일한 방법으로 추출을 진행하였다. Extraction was carried out in the same manner as in Example 1 for the lotus leaf.
그 결과 노랑 및 갈색을 띄는 pH 5.81, 비중(Specific gravity) 1.020인 연잎 추출물을 얻었다.
As a result, a lotus leaf extract having a pH of 5.81 and specific gravity of 1.020 having yellow and brown colors was obtained.
< 실시예 3> 연줄기 추출물의 제조 < Example 3> Preparation of the lotus stem extract
연줄기에 대하여 상기 실시예 1과 동일한 방법으로 추출을 진행하였다. The extraction was performed in the same manner as in Example 1 for the lotus stem.
그 결과 밝은 노란색이고, pH 5.41, 비중(Specific gravity) 1.020인 연줄기 추출물을 얻었다.
As a result, a yellow stem extract having a light yellow color, pH 5.41, and specific gravity of 1.020 was obtained.
< 실시예 4> 연꽃 추출물의 제조 <Example 4> Preparation of Lotus flower extract,
연꽃에 대하여 상기 실시예 1과 동일한 방법으로 추출을 진행하였다. Extraction was performed in the same manner as in Example 1 for the lotus.
그 결과 어두운 노란색이고, pH 5.33, 비중(Specific gravity) 1.022인 연꽃 추출물을 얻었다.
As a result, a lotus extract having a dark yellow color, a pH of 5.33 and a specific gravity of 1.022 was obtained.
< 실시예 5> 연자육 추출물의 제조 <Example 5> Preparation of extract yeonjayuk
연자육에 대하여 상기 실시예 1과 동일한 방법으로 추출을 진행하였다. Extraction was carried out in the same manner as in Example 1 with respect to the soft meat.
그 결과 갈색이고, pH 5.4, 비중(Specific gravity) 1.02인 연자육 추출물을 얻었다.
As a result, a soft, yellow-brown extract of pH 5.4 and specific gravity of 1.02 was obtained.
< 실시예 6> 연추출물의 혼합물의 제조 <Example 6> Preparation of a mixture of soft extract
연근, 연잎, 연줄기, 연자육 및 연꽃 추출물을 각각 5:1:1:1:1% 함유한 연 추출물의 혼합물을 제조하였다.
A mixture of lotus extract containing 5: 1: 1: 1: 1: 1% of lotus root, lotus leaf, lotus stem, lotus meat and lotus extract was prepared.
< 실험예 1> 중금속 분석 시험 <Experimental Example 1> Heavy metal analysis test
실시예 1 내지 5에 의한 추출물 각각에 대한 중금속 시험을 위하여 식품의약품안전청 기준 및 시험방법을 따랐다. For the heavy metal test for each of the extracts according to Examples 1 to 5, Food and Drug Administration standards and test methods were followed.
실시예 1 내지 5의 추출물을 네슬러관에 취하여 물 적당량을 넣어 녹여 40㎖로 한 후 묽은초산 2㎖ 및 물을 넣어 50㎖로 하여 검액으로 했다. 비교를 위한 비교액으로서 납표준액을 네슬러관에 취하여 묽은초산 2㎖ 및 물을 넣어 50㎖로 하였다. 실시예 1 내지 5의 추출물을 포함하는 검액 및 비교액에 황화나트륨시액 1방울씩을 넣어 흔들어 섞고, 5분간 방치한 다음 각 관을 백색 배경으로 위 또는 옆에서 관찰하여 액의 색을 비교하였다. 검액이 나타내는 색은 비교액이 나타내는 색보다 진하지 않아야 하였다.The extracts of Examples 1 to 5 were taken in a Nessler tube, dissolved in an appropriate amount of water to make 40 ml, and then diluted to 2 ml with dilute acetic acid and water to make 50 ml. As a comparison solution for comparison, a lead standard solution was taken in a Nessler tube, and 2 ml of dilute acetic acid and water were added to make 50 ml. 1 drop each of sodium sulfide solution was added to the sample solution and the comparative solution including the extracts of Examples 1 to 5, and the mixture was shaken and left to stand for 5 minutes. Each tube was observed from the top or the side of the white background to compare the color of the solution. The color of the sample solution should not be darker than the color of the comparison solution.
실험 결과, 납, 비소, 수은, 메탄올이 검출되지 않아 중금속은 불검출되는 것으로 확인되었다.
As a result, lead, arsenic, mercury, and methanol were not detected, and heavy metals were not detected.
< 실험예 2> 미생물 시험 <Experiment 2> microbiological tests
실시예 1 내지 5에 의한 추출물을 각각에 대해 식품의약품안전청 미생물 한도 기준 및 시험방법 가이드라인에 준해 시험하였다. The extracts according to Examples 1 to 5 were each tested according to the Food and Drug Administration microbial limit criteria and test method guidelines.
총 생균수를 검사하기 위하여, 직경 9-10 cm 페트리 접시 내에 미리 굳힌 변형레틴 한천배지 표면에 실시예 1 내지 5에 의한 추출물 각각의 전처리 검액 1 mL를 도말한다. 또는 검액 1 mL를 같은 크기의 페트리접시에 넣고 그 위에 멸균 후 45℃로 식힌 15mL의 배지를 넣어 잘 혼합한다. 검체당 최소 2개의 평판을 준비하고 30-35℃에서 적어도 48시간 배양하는데 이때 최대 균 집락수를 갖는 평판을 사용하되 평판당 300 개 이하의 균집락을 최대치로 하여 총 세균수를 측정하였다. 그 결과, 총생균수≤100cfu/g 이하로 불검출되는 것으로 확인되었다.To check the total viable count, 1 mL of each pretreatment sample solution of each of the extracts according to Examples 1 to 5 is smeared on the surface of the modified retinal agar medium previously hardened in a 9-10 cm diameter Petri dish. Alternatively, 1 mL of the sample solution is added to a petri dish of the same size and sterilized therein, and then 15 mL of medium cooled to 45 ° C. is mixed well. At least two plates were prepared per sample and incubated at 30-35 ° C. for at least 48 hours. The total bacterial count was measured using a plate having a maximum bacterial colony maximum but a maximum of 300 bacterial colonies per plate. As a result, it was confirmed that the total viable cell count was not detected at 100 cfu / g or less.
대장균 등의 병원균을 검사하기 위하여, 실시예 1 내지 5에 의한 추출물 각각의 검체 1g 또는 1mL를 달아 유당액체배지를 사용하여 10mL로 하여 30-35℃에서 24-72 시간 배양하였다. 배양액을 가볍게 흔든 다음 백금이 등으로 취하여 맥콘키한천배지위에 도말하고 30-35℃에서 18-24 시간 배양하였다. 주위에 적색의 침강선띠를 갖는 적갈색의 그람음성균의 집락이 검출되지 않으면 대장균 음성으로 판정할 수 있는바, 실험 결과 대장균 및 병원균은 음성 판정되어 불검출되는 것으로 확인되었다.
In order to test for pathogens such as E. coli, 1 g or 1 mL of each sample of the extracts of Examples 1 to 5 was weighed and incubated at 30-35 ° C. for 24 to 72 hours using lactose liquid medium. The solution was gently shaken and then platinum-coated and plated onto a Macconki agar medium and incubated at 30-35 ° C. for 18-24 hours. If colonies of red-brown gram-negative bacteria having a red sedimentation band around them were not detected, E. coli negatives could be determined. As a result, E. coli and pathogens were negatively determined and not detected.
< 실험예 3> 온도에 따른 저장 안정성 시험 <Experimental Example 3> Storage stability test according to the temperature
일반적으로 화장품원료의 경우에는 실온(1~30℃) 또는 상온(15~25℃)에서 1년간 외관성상 등에 변화가 없이 유지되어야 하며, 실온이나 상온의 안정도가 떨어지는 경우라도 냉장의 조건에서 최소 6개월에서 1년간 유지되어야 원료로서의 상품성이 있기 때문에 본 발명의 추출물에 대해 온도에 따른 저장 안정성을 실험하였다. In general, cosmetic raw materials should be kept at room temperature (1 ~ 30 ℃) or room temperature (15 ~ 25 ℃) for one year without any change in appearance, and at least 6, even if the stability of room temperature or room temperature is poor. Storage stability with temperature was tested for the extract of the present invention because it is commercially available as a raw material to be maintained for months to one year.
실시예 1 내지 5에 의한 추출물을 각각 상온, 40℃, 50℃, 냉장에서 보관하면서 외관성상의 변화를 관찰하였다. 아래 표 1에서 보는 바와 같이 30일간 저장하였을 경우 안정성에 문제가 없는 것으로 확인되었다.
The extracts of Examples 1 to 5 were stored at room temperature, 40 ° C., 50 ° C., and refrigerated, respectively, and observed changes in appearance. As shown in Table 1 below, when stored for 30 days it was confirmed that there is no problem in stability.
< 실험예 4> 안정성 시험 - 피부 첩포 시험(Patch Test) <Experiment 4> Stability test - skin test patch (Patch Test)
본 발명의 연 추출물의 피부 자극을 알아보기 위하여 피부 첩포 실험을 실시하였다. 피검자 20명(하기 표 2)을 대상으로 추출물 원액, 상기 실시예 1 내지 5에 의한 추출물 및 증류수를 혼합하여 전체 중량 대비 1%, 3%, 5% 농도로 만들고, 왼쪽 팔 안쪽에 Haye's test Chamber에 패치를 24시간 동안 부착 후 떼어내어 blank와 시험품의 피부반응(홍반, 부종 등)상태를 관찰해 평가하였다(Closed patch test using Haye's test Chamber). 시험은 총 2회 반복되었다. 판정은 패치 제거 후 30분, 1일, 2일, 3일 후에 걸쳐 총 4회 이루어졌으며, Draize의 P.I.I법을 기준으로 판정하였다.
Skin patch experiment was conducted to investigate the skin irritation of the lotus extract of the present invention. For 20 subjects (Table 2), extract extracts, the extracts according to Examples 1 to 5, and distilled water were mixed to make 1%, 3%, and 5% of the total weight, and Haye's test chamber was placed inside the left arm. The patch was attached for 24 hours and then detached and evaluated by observing the blank and skin reaction (erythema, edema, etc.) of the specimen (Closed patch test using Haye's test chamber). The test was repeated two times in total. Decisions were made four times over 30 minutes, 1 day, 2 days, and 3 days after patch removal, based on Draize's PII method.
① 연근① Lotus root
40명 중 2명에게 5% 추출물 희석액에서 가려움과 5% 추출물 희석에서 가벼운 홍반이 발생하였으나, 매우 가벼운 증상이었다.Two of the 40 patients developed itching in the 5% extract dilution and mild erythema in the 5% extract dilution.
② 연꽃② lotus flower
40명 중 전원 이상 없음이 확인되었다. No power failure was found in 40 people.
③ 연잎③ lotus leaf
40명 중 전원 이상 없음이 확인되었다. No power failure was found in 40 people.
④ 연줄기④ kite stem
40명 중 전원 이상 없음이 확인되었다. No power failure was found in 40 people.
⑤ 연자육 ⑤ soft breeding
40명 중 전원 이상 없음이 확인되었다.
No power failure was found in 40 people.
< 실험예 5> 연 추출물의 세포 독성에 대한 안전성 시험 (MTT assay) <
실시예 1 내지 5에 의한 연 추출물에 대한 안전성 시험이 사람섬유아세포(Human fibroblast cell)을 이용한 MTT로 측정되었다. 이 정량법은 Mosmann의 방법을 변형하여 실시한 것으로 살아있는 세포의 미토콘드리아 디하이드로게나아제(mitochondria dehydrogenase)에 의해 노란색의 수용성 기질인 MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide)가 진청색의 비수용성인 포르마잔(formazan)으로 환원되는 것을 이용한 방법이다. The safety test for the lotus extracts according to Examples 1 to 5 was measured by MTT using human fibroblast cells. This assay is a modification of Mosmann's method, which is yellow water-soluble substrate MTT (3- (4,5-dimethylthiazol-2-yl) -2,5- by mitochondria dehydrogenase of living cells. Diphenyl-tetrazolium bromide) is reduced to formazan (dark blue insoluble).
DMEM 배지에 배양된 사람섬유아세포를 배양액과 함께 96 웰(well)에 180㎕를 넣고 2시간 동안 배양하여 세포를 부착시킨 후 시료를 20㎕씩 넣은 후 24 시간 동안 배양하였다. 배양 후, 배지를 제거하고 미리 조제한 MTT (5mg/㎖ in PBS)를 200㎕ 첨가하여 다시 4시간 배양하였다. 4시간 후 배지를 제거하고 이때 형성된 어두운 파란색 결정(dark blue crystal)을 DMSO 200㎕로 용해시켜 보라색으로 생성된 포르마잔(formazan)의 양을 정량하였다. 생성된 포르마잔(formazan)의 양은 살아있는 세포수에 비례하므로 세포의 생존율을 측정할 수 있다. Human fibroblasts cultured in DMEM medium were added to the culture well with a culture solution in 96 well (180μl) and incubated for 2 hours to attach the cells, the sample was added 20μ each and incubated for 24 hours. After incubation, the medium was removed and 200 µl of MTT (5 mg / ml in PBS) prepared in advance was added and cultured again for 4 hours. After 4 hours, the medium was removed, and dark blue crystals formed at this time were dissolved in 200 μl of DMSO to quantify the amount of formazan produced in purple. Since the amount of formazan produced is proportional to the number of living cells, the viability of the cells can be measured.
세포 생존율 측정에 사용된 세포주는 human fibroblast cell line CCD-986sk 로, Korean Cell Line Bank(KCLB)에서 구입하여 사용하였다. 세포 생존율 측정 시약은 Dimethylsulphoxide(DMSO)는 sigma chemical Co.(USA)에서 구입하였으며 37℃, 5% CO2 인큐베이터에서 10% 페탈보닌세럼(Fetal Bovine Serum, FBS, JRS Inc.), 100U/mL 페니실린 및 100μg/mL 스트렙토마이신(Lonza, USA)을 혼합한 Dulbecco's modified Eagle's medium(DMEM, Lonza) 배지를 사용하였다.The cell line used for measuring cell viability was human fibroblast cell line CCD-986sk, which was purchased from Korean Cell Line Bank (KCLB). Dimethylsulphoxide (DMSO) was purchased from sigma chemical Co. (USA) and 10% Petalbonin Serum (Fetal Bovine Serum, FBS, JRS Inc.), 100U / mL penicillin at 37 ° C, 5% CO 2 incubator. And Dulbecco's modified Eagle's medium (DMEM, Lonza) medium mixed with 100 μg / mL streptomycin (Lonza, USA).
도 1에서 확인할 수 있는 바와 같이, 본 발명에 따른 추출물을 전체 중량 대비 0.1-1% 포함하는 조성물에서는 세포 독성을 나타내지 않았으나 5%에서 약간의 독성을 나타내었고 10%에서는 매우 강한 독성을 보여주었다. As can be seen in Figure 1, the composition containing 0.1-1% to the total weight of the extract according to the present invention did not show cytotoxicity, but 5% showed a slight toxicity and 10% showed a very strong toxicity.
따라서, 본 실험으로부터 연 추출물을 화장품 원료로 사용하기 위해서는 전체 중량 대비 5% 함유할 때까지가 가장 적절한 것으로 보인다. 연 추출물 중에서는 잎 추출물의 독성이 비교적 낮았다. Therefore, in order to use the lead extract as a cosmetic raw material from this experiment, it seems that it is most suitable until it contains 5% of the total weight. Among the lotus extracts, the leaf extracts had relatively low toxicity.
이상의 결과, 각각의 추출물은 전체 중량 대비 5% 함유할 때 연줄기, 연꽃, 연근, 연자육, 연잎의 순서로 세포 독성이 낮아짐을 확인하였고, 5% 이상에서는 모든 추출물에서 급격히 세포 독성이 증가함을 확인하였다.
As a result, each extract was found to lower cytotoxicity in the order of lotus stem, lotus, lotus root, lotus root, lotus leaf in 5% of the total weight, and more than 5% of all extracts rapidly increase the cytotoxicity. Confirmed.
< 실험예 6> 연 추출물의 주름개선효과 시험 < Experiment 6> Wrinkle improvement effect test of the lead extract
<실험예 6-1> 엘라스타제 억제효과시험(Elastase inhibition assay)Experimental Example 6-1 Elastase Inhibition Assay
본 발명의 연 추출물의 주름 개선 효과를 아래와 같은 엘라스타제 활성저해 효과로 테스트하였다. Wrinkle improvement effect of the lotus extract of the present invention was tested by the elastase inhibitory effect as follows.
엘라스타제는 피부진피에 존재하여 피부의 탄력을 유지하는 엘라스틴을 분해하는 효소이다. 엘라스타제 저해 물질로 알려진 아데노신(Adenosine) 0.04%을 양성 대조군으로 하여 본 발명의 연 추출물의 엘라스타제 저해활성을 측정하였다. Elastase is an enzyme that breaks down elastin in the dermis and maintains the elasticity of the skin. Elastase inhibitory activity of the lead extract of the present invention was measured using 0.04% of adenosine known as an elastase inhibitor as a positive control.
0.2M 트리스-HCl(pH 8.0) 80㎕에 3.2 mM의 Succ-Ala-Ala-Ala-p-nitroanilide 120㎕, 상기 실시예 1 내지 5의 연추출물 100 ㎕를 혼합하였다. 여기에 1U의 사람 백혈구 엘라스타제(Human Leukocytes Elastase)를 1㎖의 0.2M 트리스-HCl(pH 8.0)로 용해시킨 뒤 50㎕(50 mU)를 넣었다. 25℃에서 15분간 효소 활성화 반응을 시켰다. 반응 후 ELISA 판독기를 사용하여 415㎚에서 대조군과 각 시료의 흡광도 값을 측정하였다. 주름개선 효과를 상호비교하기 위해 100% 추출물(원액)까지 시험하였다. To 80 μl of 0.2 M Tris-HCl (pH 8.0), 120 μl of 3.2 mM Succ-Ala-Ala-Ala-p-nitroanilide and 100 μl of the soft extract of Examples 1 to 5 were mixed. Here, 1 U of human leukocytes elastase (Human Leukocytes Elastase) was dissolved in 1 ml of 0.2 M Tris-HCl (pH 8.0) and 50 μl (50 mU) was added thereto. The enzyme activation reaction was performed at 25 ° C. for 15 minutes. After the reaction, the absorbance values of the control and each sample were measured at 415 nm using an ELISA reader. Up to 100% extract (stock solution) was tested to compare the anti-wrinkle effect.
그 결과 전체 중량 대비 1-5%의 연 추출물을 함유하는 농도를 기준으로 하였을 때, 도 2에서 볼 수 있는 바와 같이, 연근, 연꽃, 연자육은 대조군인 0.04% 아데노신보다 비슷하거나 더 좋은 주름개선 효과를 보여주었다. As a result, when it is based on the concentration containing 1-5% lotus extract relative to the total weight, as shown in Figure 2, lotus root, lotus, lotus meat is similar or better than the control group 0.04% adenosine wrinkle improvement effect Showed.
이상의 결과, 각각의 추출물은 1 내지 5%에서 연자육, 연꽃, 연근, 연잎, 연줄기의 순서로 엘라스타제 억제 효과가 감소함을 확인하였다.
As a result, each extract was found to reduce the elastase inhibitory effect in the order of lotus meat, lotus, lotus root, lotus leaf, lotus stem in 1 to 5%.
<실험예 6-2> 콜라겐 합성효과시험(Collagen synthesis assay)Experimental Example 6-2 Collagen Synthesis Assay
본 발명의 연 추출물의 주름 개선 물질로서의 사용 가능성을 알아보기 위하여 콜라겐 생합성 증가를 확인할 수 있는 Procollagen Type Ⅰ C-peptide EIA kit(Takara Bio Inc. MK101)를 이용하여 콜라겐 생합성량을 측정하였으며, 그 결과를 도 3에 나타내었다. In order to examine the possibility of using the lotus extract of the present invention as an anti-wrinkle substance, collagen biosynthesis was measured using Procollagen Type I C-peptide EIA kit (Takara Bio Inc. MK101), which can confirm the increase in collagen biosynthesis. Is shown in FIG. 3.
96-웰 플레이트의 각 웰에 항체-POD(horseradish peroxidase) 컨쥬게이트 용액 100㎕를 넣고 1/2씩 미리 희석해둔 표준물질(PIP 640 ng/㎖)과 동일한 양의 상기 연 추출물을 넣고 잘 혼합한 후, 37℃에서 3시간 동안 반응시켰다. 3시간 후 안의 반응물을 제거한 웰에 PBS 400㎕를 첨가하여 4회 정도 세척하고, 기질을 100㎕씩 첨가한 후 20~30℃에서 15분간 반응시켰다. 그런 다음 정지용액(stop solution, 1N H2SO4)을 100㎕씩 첨가하여 청록색에서 노란색으로 변한 반응물의 흡광도를 450㎚에서 측정하였다. 양성대조군으로는 아데노신을 사용하였으며, 0.04%에서 처리하였다.Add 100 μl of antibody-horseradish peroxidase (POD) conjugate solution to each well of a 96-well plate, add the same amount of the lead extract as the standard (PIP 640 ng / ml) diluted in half, and mix well. After that, the reaction was carried out at 37 ° C. for 3 hours. After 3 hours, 400 µl of PBS was added to the wells from which the reaction product was removed, and washed about 4 times. The substrate was reacted for 15 minutes at 20 to 30 ° C. after adding 100 µl of the substrate. Then, 100 μl of stop solution (1N H 2 SO 4 ) was added thereto, and the absorbance of the reactant turned from blue green to yellow was measured at 450 nm. Adenosine was used as a positive control and treated at 0.04%.
시험 농도범위는 0.1-5%를 사용하였으며, 도 3에서 볼 수 있는 바와 같이, 콜라겐 합성효과는 0.5-1% 연자육에서 가장 우수하였고, 연꽃, 연줄기, 연근에서도 대조군인 0.04% 아데노신보다 우수하였다. 그러나 5%의 농도에서는 그 효과가 관찰되지 않았다. 따라서 연자육, 연꽃, 연줄기를 1% 함유한 추출물이 주름개선 화장품소재로서 가장 가능성이 높은 것으로 판단된다.
The concentration range of test was 0.1-5%, and as shown in FIG. 3, collagen synthesis effect was the best in 0.5-1% lotus root, and better than the control group 0.04% adenosine in lotus, lotus stem and lotus root. . However, the effect was not observed at the concentration of 5%. Therefore, extract containing 1% of lotus root, lotus, and lotus stem is considered the most likely as a wrinkle improvement cosmetic material.
< 실험예 7> 화장품 제형의 안정성 시험 <Experiment 7> Stability test of cosmetic formulations
상기 실시예 6에 의한 연 추출물의 혼합물을 이용하여 제조된 화장품 제형, 즉 수분크림, 에센스, 크림의 안정성을 시험하였다. Haye's test Chamber에 증류수를 사용하여 상기 실시예 6에서 제조한 연 추출물 혼합물 원액, 1%, 3%, 5% 농도로 조정하고 왼쪽 팔 안쪽에 패치를 24시간 동안 부착 후 떼어내어 blank와 시험품의 피부반응(홍반, 부종 등)상태를 관찰해 평가하였다(Closed patch test using Haye's test Chamber). 시험은 총 2회 반복되었다. The stability of the cosmetic formulation, ie, moisture cream, essence and cream, prepared using the mixture of the lotus extract according to Example 6 was tested. Using the distilled water in Haye's test chamber, adjust the concentration of the crude extract mixture prepared in Example 6, 1%, 3%, 5%, and attach the patch to the inside of the left arm for 24 hours, and then peel off the skin of the blank and the test article. The state of reaction (erythema, edema, etc.) was observed and evaluated (Closed patch test using Haye's test chamber). The test was repeated two times in total.
판정은 패치 제거 후 30분, 1일, 2일, 3일 후에 걸쳐 총 4회 이루어졌으며, Draize의 P.I.I법을 기준으로 판정하였다. 시험 대상은 표 2와 동일하다. Decisions were made four times over 30 minutes, 1 day, 2 days, and 3 days after patch removal, based on Draize's P.I.I method. Test objects are the same as in Table 2.
① 수분크림① Moisture Cream
40명 중 전원 이상 없음이 확인되었다. No power failure was found in 40 people.
② 에센스② essence
40명 중 전원 이상 없음이 확인되었다. No power failure was found in 40 people.
③ 크림③ cream
40명 중 전원 이상 없음이 확인되었다. No power failure was found in 40 people.
Claims (7)
ii) 상기 i)단계에서 분리된 연꽃, 연잎, 연줄기, 연근, 연자육을 각각 별도로 100 g 당 용매 3000 ml 내지 4000 ml를 가하고 100℃ 내지 120℃에서 최초 부피의 50%의 부피가 될 때까지 가열하여 열수 추출하고 각각 냉각하는 단계;
iii) 상기 ii)단계에서 얻어진 냉각된 연꽃, 연잎, 연줄기, 연근, 연자육의 열수 추출물을 각각 1차 여과하는 단계;
iv) 상기 iii)단계에서 얻어진 연꽃, 연잎, 연줄기, 연근, 연자육의 열수 추출물을 각각 4℃ 내지 6℃에서 24시간 침지시키는 단계; 및
v) 상기 iv)단계에서 얻어진 연꽃, 연잎, 연줄기, 연근, 연자육의 열수 추출물을 각각 2차 여과하는 단계;에 의해 제조된 연꽃, 연잎, 연줄기, 연근 및 연자육의 열수 추출물을 전체 화장료 조성물 대비 각각 0.01 중량% 내지 5 중량% 함유하는 것을 특징으로 하는 주름 개선 효과를 가지는 화장료 조성물.
i) separating the lotus, lotus leaf, lotus stem, lotus root, lotus meat;
ii) Add the lotus flower, lotus leaf, lotus stem, lotus root, and lotus root meat separated in step i) to 3,000 ml to 4000 ml of solvent per 100 g each, until the volume is 50% of the original volume at 100 ° C to 120 ° C. Heating to extract hydrothermal and cooling respectively;
iii) primary filtration of the hydrothermal extracts of the cooled lotus, lotus leaf, lotus stem, lotus root and lotus root meat obtained in step ii);
iv) immersing hot water extracts of lotus, lotus leaf, lotus stem, lotus root and lotus root meat obtained in step iii) at 4 ° C. to 6 ° C. for 24 hours; And
v) filtering the hot water extracts of lotus flower, lotus leaf, lotus stem, lotus root, and lotus root meat respectively, obtained in step iv); and the hot water extracts of lotus flower, lotus leaf, lotus stem, lotus root and lotus root muscle, respectively. Cosmetic composition having a wrinkle improvement effect, characterized in that containing 0.01 to 5% by weight, respectively.
상기 ii)단계의 열수 추출 단계를 2회 내지 5회 반복하는 것을 특징으로 하는 주름 개선 효과를 가지는 화장료 조성물.
The method of claim 1,
Cosmetic composition having a wrinkle-improving effect, characterized in that to repeat the hot water extraction step of step ii) 2 to 5 times.
상기 용매는 정제수를 포함한 물, 에탄올을 포함하는 C1 내지 C4의 저급알콜, 글리세린, 부틸렌글리콜, 프로필렌글리콜, 함수 에탄올, 함수 프로필렌글리콜, 함수 부틸렌글리콜로 구성된 그룹으로부터 선택된 하나 이상인 것을 특징으로 하는 주름 개선 효과를 가지는 화장료 조성물.
The method of claim 1,
The solvent is at least one selected from the group consisting of water containing purified water, C 1 to C 4 lower alcohol containing ethanol, glycerin, butylene glycol, propylene glycol, hydrous ethanol, hydrous propylene glycol, hydrous butylene glycol Cosmetic composition which has a wrinkle improvement effect made into.
상기 화장료 조성물은 스킨로션, 스킨소프너, 스킨토너, 아스트린젠트, 로션, 밀크로션, 모이스쳐 로션, 영양로션, 맛사지크림, 영양크림, 모이스처크림, 핸드크림, 파운데이션, 에센스, 영양에센스, 팩, 비누, 클렌징폼, 클렌징로션, 클렌징크림, 바디로션 및 바디클린저의 제형으로 구성된 그룹에서 선택된 하나 이상의 제형을 가짐을 특징으로 하는 주름 개선 효과를 가지는 화장료 조성물.The method of claim 1,
The cosmetic composition is a skin lotion, skin softener, skin toner, astringent, lotion, milk lotion, moisturizing lotion, nutrition lotion, massage cream, nutrition cream, moisturizing cream, hand cream, foundation, essence, nutrition essence, pack, soap, cleansing A cosmetic composition having an anti-wrinkle effect, characterized in that it has at least one formulation selected from the group consisting of foams, cleansing lotions, cleansing creams, body lotions and body cleansers.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100034504A KR101229045B1 (en) | 2010-04-14 | 2010-04-14 | Extracting method of nelumbo nucifera flower, leaf, stem, root, seed and cosmetic composition for anti-wrinkle containing extracts thereby |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100034504A KR101229045B1 (en) | 2010-04-14 | 2010-04-14 | Extracting method of nelumbo nucifera flower, leaf, stem, root, seed and cosmetic composition for anti-wrinkle containing extracts thereby |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20110115047A KR20110115047A (en) | 2011-10-20 |
KR101229045B1 true KR101229045B1 (en) | 2013-02-04 |
Family
ID=45029829
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020100034504A Active KR101229045B1 (en) | 2010-04-14 | 2010-04-14 | Extracting method of nelumbo nucifera flower, leaf, stem, root, seed and cosmetic composition for anti-wrinkle containing extracts thereby |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101229045B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101837960B1 (en) * | 2015-09-18 | 2018-03-13 | 유씨엘 주식회사 | Anti-wrinkle composition comprising extracts of nelumbo nucifera roots, and willow or propolis |
CN116640109A (en) * | 2023-05-31 | 2023-08-25 | 长沙智生源生物科技有限公司 | Lotus seed extract and extraction method and application thereof |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101426592B1 (en) * | 2012-05-07 | 2014-08-05 | 인제대학교 산학협력단 | Composition for preventing UV-induced skin aging comprising the extract of Nelumbinis Semen |
KR20160092165A (en) | 2015-01-27 | 2016-08-04 | 주식회사 대한바이오위드 | Method of manufacturing cosmetic containing extracts of nelumbo nucifera |
KR102054100B1 (en) * | 2019-03-06 | 2020-01-22 | 휘조우 맨내이 바이오로지컬 테크놀로지 컴퍼니 리미티드 | Cosmetic composition containing fermented extract of roots |
KR102533787B1 (en) * | 2020-11-11 | 2023-05-18 | (주)아멍코스메틱 | Antioxidant effect on flavonoids and polyphenols of Ceratopteris thalictroides extract, and cosmetic composition for preventing skin aging, or for preventing or improving skin wrinkles |
KR102381645B1 (en) * | 2021-10-18 | 2022-04-01 | 박선규 | Cosmetic Composition Comprising Poria cocos Fermentation Extract |
KR102418247B1 (en) * | 2022-02-08 | 2022-07-06 | 박성아 | Method for producing cosmetic composition containing natural substance extract, which is effective for slow aging and clear-transparent skin |
CN116473885A (en) * | 2022-12-28 | 2023-07-25 | 澳宝化妆品(惠州)有限公司 | Skin care cream containing olive tender bud extract and lotus flower extract and preparation method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5925348A (en) | 1996-02-23 | 1999-07-20 | Medical Doctor's Research Institute, Inc. | Methods utilizing compositions containing sacred lotus (methyltransferase) to treat aging skin |
US20020098253A1 (en) * | 1996-02-23 | 2002-07-25 | Riley Patricia A. | Oral compositions containing lotus |
KR100678869B1 (en) | 2005-09-27 | 2007-02-05 | 함양 지리산 영농조합법인 | Manufacturing method of beverage containing herbal extract including earthberry |
KR100828193B1 (en) * | 2006-11-06 | 2008-05-08 | 박영준 | Whitening, anti-aging and antiwrinkle composition containing lotus extract |
-
2010
- 2010-04-14 KR KR1020100034504A patent/KR101229045B1/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5925348A (en) | 1996-02-23 | 1999-07-20 | Medical Doctor's Research Institute, Inc. | Methods utilizing compositions containing sacred lotus (methyltransferase) to treat aging skin |
US20020098253A1 (en) * | 1996-02-23 | 2002-07-25 | Riley Patricia A. | Oral compositions containing lotus |
KR100678869B1 (en) | 2005-09-27 | 2007-02-05 | 함양 지리산 영농조합법인 | Manufacturing method of beverage containing herbal extract including earthberry |
KR100828193B1 (en) * | 2006-11-06 | 2008-05-08 | 박영준 | Whitening, anti-aging and antiwrinkle composition containing lotus extract |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101837960B1 (en) * | 2015-09-18 | 2018-03-13 | 유씨엘 주식회사 | Anti-wrinkle composition comprising extracts of nelumbo nucifera roots, and willow or propolis |
CN116640109A (en) * | 2023-05-31 | 2023-08-25 | 长沙智生源生物科技有限公司 | Lotus seed extract and extraction method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
KR20110115047A (en) | 2011-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101229045B1 (en) | Extracting method of nelumbo nucifera flower, leaf, stem, root, seed and cosmetic composition for anti-wrinkle containing extracts thereby | |
KR102121944B1 (en) | Cosmetic composition comprising extract of bud of Nypa fruiticans | |
KR20070115507A (en) | Skin external composition for acne skin improvement containing German Iris, Centella, Chamomile, Evening Primrose and Echo extract | |
KR101800161B1 (en) | Wheat seed extract showing potent inhibiting effect on skin aging, the preparation thereof and the compostion comprising the same | |
KR20140076240A (en) | Cosmetic composition for improving atopy dermatitis containing fermented herb extract | |
KR102079263B1 (en) | Method for refining horse oil and Cosmetic composition using refined horse oil manufactured therefrom | |
KR102121302B1 (en) | Cosmetic composition using Cinnamomum camphora extract | |
KR102517579B1 (en) | Freeze-dried feminine cleanser containing natural extract as an active ingredient | |
KR20210048021A (en) | Antibacterial compositions comprising the citrus aurantium sinensis peel extract, the magnolia officinalis bark extract and polylysine | |
KR102618301B1 (en) | Cosmetic composition comprising probiotics culture | |
KR100829831B1 (en) | Whitening cosmetic composition containing plant extract | |
KR102252855B1 (en) | Cosmetic composition comprising nano-ized lactobacillus genus dead cells and a method for producing the same | |
KR102111085B1 (en) | Method for fermenting polygonum indigo using nuruk and Cosmetic composition using fermented polygonum indigo extract obtained by the same | |
KR100706285B1 (en) | External skin composition containing platinum extract having anti-wrinkle and improving activity | |
KR20190098603A (en) | Cosmetic composition comprising microorganism femented produsts with moisturizing effects | |
KR101230588B1 (en) | Cosmetic composition containing natural vitamin and plant complex extract | |
KR101203273B1 (en) | Cosmetic composition comprising the extract of Porphyra tenera showing anti-bacterial activities | |
KR102121303B1 (en) | Cosmetic composition using Dendropanax morbiferus extract | |
KR101267765B1 (en) | A preparation method for PSE extract of Prunella vulgaris having antioxidative effect and the cosmetic composition comprising the same | |
KR102803361B1 (en) | Phellinus linteus mycelium fermentation composition of Chamaecyparis obtusa extract and use thereof | |
KR102659125B1 (en) | Cosmetic composition comprising probiotics cultivatied using dogo hot spring water | |
KR20130073040A (en) | A composition comprising hemistepsin a or b isolated from the extract of hemistepita lyrata bunge for preventing and treating dandruff | |
KR102217895B1 (en) | Cosmetic composition using Thymus quinquecostatus Celak extract and Dendropanax morbiferus extract | |
KR20250089764A (en) | Antioxidant, anti-inflammatory, skin soothing and wound healing composition containing complex fermented extract as an active ingredient, and cosmetic composition containing the same | |
KR20240047133A (en) | Cosmetic composition comprising probiotics cultivatied using hot spring water and plant complex extract as active ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20100414 |
|
PA0201 | Request for examination | ||
PG1501 | Laying open of application | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20120419 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20121101 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20130128 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20130129 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
FPAY | Annual fee payment |
Payment date: 20151229 Year of fee payment: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20151229 Start annual number: 4 End annual number: 4 |
|
FPAY | Annual fee payment |
Payment date: 20181231 Year of fee payment: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20181231 Start annual number: 7 End annual number: 7 |
|
FPAY | Annual fee payment |
Payment date: 20200113 Year of fee payment: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20200113 Start annual number: 8 End annual number: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20210125 Start annual number: 9 End annual number: 9 |
|
PR1001 | Payment of annual fee |
Payment date: 20220127 Start annual number: 10 End annual number: 10 |
|
PR1001 | Payment of annual fee |
Payment date: 20240125 Start annual number: 12 End annual number: 12 |